{"metadata": {"review_pmid": "39932103"}, "inputs": {"background": "Various approaches to physical rehabilitation to improve function and mobility are used after stroke. There is considerable controversy around the relative effectiveness of approaches, and little known about optimal delivery and dose. Some physiotherapists base their treatments on a single approach; others use components from several different approaches.", "objectives": "Primary objective: To determine whether physical rehabilitation is effective for recovery of function and mobility in people with stroke, and to assess if any one physical rehabilitation approach is more effective than any other approach.", "selection criteria": "Inclusion criteria: Randomised controlled trials (RCTs) of physical rehabilitation approaches aimed at promoting the recovery of function or mobility in adult participants with a clinical diagnosis of stroke."}, "labels": ["23216861", "33190615", "26600952", "17702703", "35964211", "35459194", "35459194", "34290663", "31707972", "22819061", "23600965", "25037002", "18955423", "22503739", "21612471", "27418997", "15574110", "21788266", "29412167", "28603356", "16634338", "29270204", "30501977", "32890770", "26504340", "24259927", "19704158", "27107979", "29413790", "10768528", "19624858", "22544817", "30010509", "30010509", "32811378", "9756581", "12920254", "33324926", "12971705", "22510162", "25118156", "29706442", "30368324", "11812553", "15137555", "36447690", "29859180", "21037954", "23901675", "15704508", "18036303", "19509438", "27347547", "35036254", "29545693", "2741997", "25538853", "25140077", "26957751", "28626306", "30656163", "34684135", "29529870", "26409399", "24708038", "27585746", "22861816", "11991797", "19674485", "22577186", "21110413", "14606738", "10945420", "17613581", "29284737", "23227428", "32252739", "26055635", "26055635", "25357149", "29961738", "21036118", "15774435", "26891641", "24668360", "26048054", "30121600", "26048054", "15743283", "28371936", "33136078", "15482247", "31409536", "36147622", "25538152", "26763949", "26220327", "19969159", "31453532", "28885236", "36115574", "20719820", "25506618", "25920470", "16181164", "30571419", "32891079", "24982002", "33164953", "26316552", "27697876", "29449290", "34767488", "1409875", "8503751", "15293485", "26180312", "24355995", "25642070", "35241176", "29588861", "31296113", "35255091", "10527076", "17426347", "19821873", "25576474", "27415645", "27341068", "22120031", "1559090", "15759530", "24788580", "32978194", "34188460", "36445316", "8630191", "33002792", "14970894", "25514822", "17008338", "18780882", "15730802", "15730803", "26728501", "22875557"]}
{"metadata": {"review_pmid": "39878158"}, "inputs": {"background": "Electronic cigarettes (ECs) are handheld electronic vaping devices that produce an aerosol by heating an e-liquid. People who smoke, healthcare providers, and regulators want to know if ECs can help people quit smoking, and if they are safe to use for this purpose. This is a review update conducted as part of a living systematic review.", "objectives": "To examine the safety, tolerability, and effectiveness of using EC to help people who smoke tobacco achieve long-term smoking abstinence, in comparison to non-nicotine EC, other smoking cessation treatments, and no treatment.", "selection criteria": "We included trials randomizing people who smoke to an EC or control condition. We included uncontrolled intervention studies in which all participants received an EC intervention. Studies had to report an eligible outcome."}, "labels": ["25358095", "38354139", "35380498", "39827790", "29304395", "34859526", "31779689", "31779689", "24485579", "24029165", "23496861", "25814920", "27322745", "23826093", "27543458", "26749533", "26729619", "23358230", "33723598", "37014673", "31956726", "29127080", "30500925", "37753443", "33857436", "34850164", "26941050", "30393015", "30365024", "35752091", "35752091", "35752091", "32389072", "30203076", "33095798", "35134961", "28718828", "35869375", "33170240", "32462131", "37832989", "33988520", "36727168", "30006020", "31740017", "27613896", "32770246", "30071863", "30699054", "31434605", "31597207", "33430407", "36344702", "35577966", "38229538", "37840301", "29791259", "30290121", "31828315", "29986786", "31171977", "29335291", "32343994", "36450821", "37505530", "33756301", "34128486", "28376818", "35971150", "34827200", "27097389", "30280019", "31300577", "31300577", "31838445", "36421329", "26842790", "30239904", "29660034", "35614523", "34175001", "28648969", "35491736", "31578724", "26333731", "27613880", "26444980", "34929031", "34435305", "34187081", "24629555", "34669956", "25762758", "31470240", "26184244", "21989407", "23873169", "25380748", "25811767", "36657751", "38531658", "27043170", "35363874", "35820869", "28003511", "33837422", "33837422", "34105208", "34105208", "36857841", "35351805", "33206193", "35022796", "35022796", "34284312", "34284312", "37458789", "34753488", "33046080", "34536632", "35405479", "31403695", "26712843", "27942543", "35738868", "35742698", "26783292", "29083287", "24148175", "35575085", "27932811", "27769828", "29248487", "31515173", "30808668", "35995103", "38127516", "31698920"]}
{"metadata": {"review_pmid": "39804128"}, "inputs": {"background": "Cognitive stimulation (CS) is an intervention for people with dementia offering a range of enjoyable activities providing general stimulation for thinking, concentration and memory, usually in a social setting, such as a small group. CS is distinguished from other approaches such as cognitive training and cognitive rehabilitation by its broad focus and social elements, aiming to improve domains such as quality of life (QoL) and mood as well as cognitive function. Recommended in various guidelines and widely implemented internationally, questions remain regarding different modes of delivery and the clinical significance of any benefits. A systematic review of CS is important to clarify its effectiveness and place practice recommendations on a sound evidence base. This review was last updated in 2012.", "objectives": "To evaluate the evidence for the effectiveness of CS for people with dementia, including any negative effects, on cognition and other relevant outcomes, accounting where possible for differences in its implementation.", "selection criteria": "We included all randomised controlled trials (RCTs) of CS for dementia published in peer review journals in the English language incorporating a measure of cognitive change."}, "labels": ["33393364", "33089699", "15374320", "14764370", "16323385", "21483095", "27272538", "33437991", "15603468", "30370782", "30200025", "25525349", "32252544", "22133165", "22468985", "23217188", "33104028", "35012439", "25656505", "31320931", "28881430", "31930518", "31906723", "22495338", "24052800", "32881071", "27497474", "16260821", "26292178", "28350796", "24628705", "22573599", "20426866", "25528281", "24676963", "28222815", "35221680", "15084794", "16954689", "16738349", "12948999", "33140499", "29781725"]}
{"metadata": {"review_pmid": "39679851"}, "inputs": {"background": "Sample collection is a key driver of accuracy in the diagnosis of SARS-CoV-2 infection. Viral load may vary at different anatomical sampling sites and accuracy may be compromised by difficulties obtaining specimens and the expertise of the person taking the sample. It is important to optimise sampling accuracy within cost, safety and accessibility constraints.", "objectives": "To compare the sensitivity of different sampling collection sites and methods for the detection of current SARS-CoV-2 infection with any molecular or antigen-based test.", "selection criteria": "We included studies of symptomatic or asymptomatic people with suspected SARS-CoV-2 infection undergoing testing. We included studies of any design that compared results from different sample types (anatomical location, operator, collection device) collected from the same participant within a 24-hour period."}, "labels": ["32944044", "32944044", "32946791", "33387561", "33618013", "33053493", "34735503", "33217552", "34309674", "34942043", "34324212", "33295640", "33937007", "34132579", "33338623", "33338623", "33338623", "34877351", "34877351", "34478943", "34406838", "34406838", "34406838", "34406838", "34076471", "33582823", "34363772", "34363772", "34387653", "32462195", "34304090", "34273438", "34668736", "34668736", "34668736", "34668736", "33482729", "34619381", "33527375", "34926372", "34816515", "33419948", "33419948", "33419948", "34250969", "35215902", "35215902", "34406222", "33674284", "33674284", "32935807", "32935807", "33912522", "34351984", "33581365", "33808815", "33808815", "33808815", "33886872", "33940004", "34342768", "34342768", "34342768", "34028625", "34448088", "33075138", "36862684", "36862684", "32750665", "32621616", "34144452", "34960630", "34327228", "34877351", "34877351", "34877351", "34877351", "34877351", "34877351", "33236269", "32414838", "32697321", "35728458", "33986939", "33986939", "33986939", "34358676", "34358676", "34358676", "34358676", "34358676", "34358676", "34358676", "34358676", "34358676", "34358676", "34358676", "34358676", "32781366", "34364098", "34364098", "34364098", "34364098", "34364098", "34364098", "35162294", "35162294", "32703816", "34516569", "34516569", "32770241", "32422408", "33527126", "35671206", "32295896", "32727828", "34491341", "32883744", "34771026", "34771026", "34771026", "33393672", "33393672", "33957320", "34173660", "34004419", "36827328", "36827328", "33061486", "32688069", "34286681", "33542443", "33542443", "33217472", "32492294", "32492294", "32492294", "32492294", "34730436", "32888905", "32295895", "32711040", "32666481", "36706119", "36706119", "32315809", "32403007", "32317257", "34259547"]}
{"metadata": {"review_pmid": "39651635"}, "inputs": {"background": "Multiple sclerosis (MS) is an immune-mediated, chronic, inflammatory demyelinating disease of the central nervous system, impacting around 2.8 million people worldwide. Characterised by recurrent relapses or progression, or both, it represents a substantial global health burden, affecting people, predominantly women, at a young age (the mean age of diagnosis is 32 years). Azathioprine is used to treat chronic inflammatory and autoimmune diseases, and it is used in clinical practice as an off-label intervention for MS, especially where access to on-label disease-modifying treatments (DMTs) for MS is limited. Given this, a review of azathioprine's benefits and harms would be timely and valuable to inform shared healthcare decisions.", "objectives": "To evaluate the benefits and harms of azathioprine (AZA) for relapsing and progressive multiple sclerosis (MS), compared to other disease-modifying treatments (DMTs), placebo or no treatment. Specifically, we will assess the following comparisons. AZA compared with other DMTs or placebo as first-choice treatment for relapsing forms of multiple sclerosis AZA compared with other DMTs or placebo for relapsing forms of MS when switching from another DMT AZA compared with other DMTs or placebo as first-choice treatment for progressive forms of MS AZA compared with other DMTs or placebo for progressive forms of MS when switching from another DMT", "selection criteria": "We included randomised controlled trials (RCTs) lasting 12 months or more that compared azathioprine versus DMTs, placebo or no intervention in adults with MS. We considered evidence from non-randomised studies of interventions (NRSIs) as these studies may provide additional evidence not available from RCTS. We excluded cluster-randomised trials, cross-over trials, interrupted time series, case reports and studies of within-group design with no control group."}, "labels": ["8469348", "2899660", "3316505", "3359729", "14748776", "8649558", "2668784", "18074075", "1985289", "19465443", "17550987", "19168190", "22402204", "3278672", "3050587", "2147900", "25402490", "3281916", "8326334", "11181879", "16764353", "4632435"]}
{"metadata": {"review_pmid": "39625073"}, "inputs": {"background": "Pressure ulcers occur when people cannot reposition themselves to relieve pressure over bony prominences. They are difficult to heal, costly, and reduce quality of life. Dressings and topical agents (lotions, creams, and oils) for pressure ulcer prevention are widely used. However, their effectiveness is unclear. This is the third update of this review.", "objectives": "To evaluate the effects of dressings and topical agents on pressure ulcer prevention, in people of any age without existing pressure ulcers, but at risk of developing one, in any healthcare setting.", "selection criteria": "We included randomised controlled trials that enroled people at risk of developing a pressure ulcer."}, "labels": ["31780037", "33216969", "32379165", "32740180", "31184996", "31475465", "26075375", "33314605", "35284353", "35284353", "23199818", "29314659", "35124474", "33201144", "32391627", "31628863", "31628863", "30268162", "25942326", "27802960", "32021369", "30793860", "35809008", "25886152", "17681081", "33124968", "28277990", "31929213", "23711244", "24750780", "29635842", "32891284", "15779642", "3332839", "23166914", "25296647", "32649485"]}
{"metadata": {"review_pmid": "39601298"}, "inputs": {"background": "As the burden of cardiovascular disease grows, so does the number of cardiac surgeries. Surgery is increasingly performed on older people with comorbidities who are at higher risk of developing perioperative complications such as low cardiac output state (LCOS). Surgery-associated LCOS represents a serious pathology responsible for substantial morbidity and mortality. Prevention of LCOS is a critical and worthwhile aim to further improve the outcome and effectiveness of cardiac surgery. However, guidelines consistently report a lack of evidence for pharmacological LCOS prophylaxis.", "objectives": "To assess the benefits and harms of the prophylactic use of any inotropic agent to prevent low cardiac output and associated morbidity and mortality in adults undergoing cardiac surgery.", "selection criteria": "We included randomised controlled trials (RCTs) enrolling adults who underwent cardiac surgery and were prophylactically treated with one or multiple inotropic agent(s) in comparison to any type of control (i.e. standard cardiac care, placebo, other inotropic agents)."}, "labels": ["27378790", "24447501", "28787507", "17377079", "27470232", "29652271", "24781725", "19161758", "24217302", "23287080", "15016048", "24338139", "18922425", "20740213", "25348510", "28393781", "11772795", "23545863", "21666445", "21258075", "23620700", "28316276", "27321790", "24550581", "24867027", "16595616", "19151048"]}
{"metadata": {"review_pmid": "39588800"}, "inputs": {"background": "Paediatric patients undergoing surgery for congenital heart disease (CHD) are at risk for postoperative low cardiac output syndrome (LCOS) and mortality. LCOS affects up to 25% of children after heart surgery. It consists of reduced myocardial function and increases postoperative morbidity, prolongs mechanical ventilation, and lengthens the duration of intensive care unit (ICU) stay. Pharmacological prophylaxis involves inotropes, including catecholamines, phosphodiesterase III inhibitors, or calcium sensitisers, to enhance myocardial contractility. It is unclear whether they are effective in preventing LCOS or death in this vulnerable population.", "objectives": "1. To evaluate the relative benefits and harms of inotropes for the prevention of LCOS and mortality in paediatric patients undergoing surgery for CHD. 2. To generate a clinically useful ranking of prophylactic inotropes for the prevention of LCOS and mortality in paediatric patients undergoing surgery for CHD according to benefits and harms.", "selection criteria": "We included randomised controlled trials comparing inotropes from one drug class (catecholamines, phosphodiesterase type III inhibitors, calcium sensitisers) to another (either alone or in combination) or placebo, in paediatric patients (birth to 18 years of age) undergoing surgery for CHD."}, "labels": ["33367965", "29538053", "24906491", "24906491", "24906491", "23223915", "11773907", "12600913", "33884979", "22622649", "20829069", "23138399", "22527079", "31274775", "33739957", "32201198", "31888711"]}
{"metadata": {"review_pmid": "39474992"}, "inputs": {"background": "Peripheral arterial disease (PAD) of the lower limbs is caused by atherosclerotic occlusive disease in which narrowing of arteries reduces blood flow to the lower limbs. PAD is common; it is estimated to affect 236 million individuals worldwide. Advanced age, smoking, hypertension, diabetes and concomitant cardiovascular disease are common factors associated with increased risk of PAD. Complications of PAD can include claudication pain, rest pain, wounds, gangrene, amputation and increased cardiovascular morbidity and mortality. It is therefore clinically important to use diagnostic tests that accurately identify PAD. Accurate and timely detection of PAD allows clinicians to implement appropriate risk management strategies to prevent complications, slow progression or intervene when indicated. Toe-brachial index (TBI) and toe systolic blood pressure (TSBP) are amongst a suite of non-invasive bedside tests used to detect PAD. Both TBI and TSBP are commonly utilised by a variety of clinicians in different settings, therefore a systematic review and meta-analysis of their diagnostic accuracy is warranted and highly relevant to inform clinical practice.", "objectives": "To (1) estimate the accuracy of TSBP and TBI for the diagnosis of PAD in the lower extremities at different cut-off values for test positivity in populations at risk of PAD, and (2) compare the accuracy of TBI and TSBP for the diagnosis of PAD in the lower extremities. Secondary objectives were to investigate several possible sources of heterogeneity in test accuracy, including the following: patient group tested (people with type 1 or type 2 diabetes, people with renal disease and general population), type of equipment used, positivity threshold and type of reference standard.", "selection criteria": "We included diagnostic case-control, cross-sectional, prospective and retrospective studies in which all participants had either a TSBP or TBI measurement plus a validated method of vascular diagnostic imaging for PAD. We needed to be able to cross-tabulate (2 x 2 table) results of the index test and the reference standard to include a study. To be included, study populations had to be adults aged 18 years and over. We included studies of symptomatic and asymptomatic participants. Studies had to use TSBP and TBI (also called toe-brachial pressure index (TBPI)), either individually, or in addition to other non-invasive tests as index tests to diagnose PAD in individuals with suspected disease. We included data collected by photoplethysmography, laser Doppler, continuous wave Doppler, sphygmomanometers (both manual and aneroid) and manual or automated digital equipment."}, "labels": ["31471230", "31624003", "34583809", "37120264", "34956078", "37892678", "34275312", "32029491", "33630461", "16860193", "22783531", "38414018", "28423999", "26281971", "29270232", "34488499", "23641284", "29633431", "16123491"]}
{"metadata": {"review_pmid": "39470185"}, "inputs": {"background": "Adverse drug events, encompassing both adverse drug reactions and medication errors, pose a significant threat to health, leading to illness and, in severe cases, death. Timely and voluntary reporting of adverse drug events by healthcare professionals plays a crucial role in mitigating the morbidity and mortality linked to unexpected reactions and improper medication usage.", "objectives": "To assess the effectiveness of different interventions aimed at healthcare professionals to improve the reporting of adverse drug events.", "selection criteria": "We included randomised trials, non-randomised controlled studies, controlled before-after studies, interrupted time series studies (ITS) and repeated measures studies, assessing the effect of any intervention aimed at healthcare professionals and designed to increase adverse drug event reporting. Eligible comparators were healthcare professionals' usual reporting practice or a different intervention or interventions designed to improve adverse drug event reporting rate. We excluded studies of interventions targeted at adverse event reporting following immunisation. Our primary outcome measures were the total number of adverse drug event reports (including both adverse drug reaction reports and medication error reports) and the number of false adverse drug event reports (encompassing both adverse drug reaction reports and medication error reports) submitted by healthcare professionals. Secondary outcomes were the number of serious, high-causality, unexpected or previously unknown, and new drug-related adverse drug event reports submitted by healthcare professionals. We used GRADE to assess the certainty of evidence."}, "labels": ["30283626", "14583065", "28675578", "16954488", "18366244", "22788235", "19127360", "21899766", "25537234", "25252388", "19132807", "21085884", "22468615", "10427579"]}
{"metadata": {"review_pmid": "39324693"}, "inputs": {"background": "Malaria and HIV infection overlap geographically in sub-Saharan Africa and share risk factors. HIV infection increases malaria's severity, especially in pregnant women. The World Health Organization (WHO) recommends intermittent preventive treatment in pregnancy (IPTp) with sulphadoxine-pyrimethamine (SP) for pregnant women living in areas of stable malaria transmission. However, HIV-positive women on daily cotrimoxazole prophylaxis (recommended for prevention of opportunistic infections in people with HIV) cannot receive SP due to adverse drug interactions, so malaria prevention in this vulnerable population currently relies on daily cotrimoxazole prophylaxis alone. This review is based on a new protocol and provides an update to the 2011 Cochrane Review that evaluated alternative drugs for IPTp to prevent malaria in HIV-positive women.", "objectives": "To compare the safety and efficacy of intermittent preventive treatment regimens for malaria prevention in HIV-positive pregnant women.", "selection criteria": "We included randomized controlled trials (RCTs) comparing any intermittent preventive treatment regimen for preventing malaria in HIV-positive pregnant women against daily cotrimoxazole prophylaxis alone, placebo, current or previous standard of care, or combinations of these options. By 'standard of care' we refer to the country's recommended drug regimen to prevent malaria in pregnancy among HIV-positive women, or the treatment that a trial's research team considered to be the standard of care."}, "labels": ["29719927", "31140565", "38224710", "24220287", "24220287", "16826475", "25247995", "34815285", "38224706", "18008241", "24336820", "34407273", "24830749", "18398460", "18651857", "28329368"]}
{"metadata": {"review_pmid": "39319863"}, "inputs": {"background": "Dementia and mild cognitive impairment are significant contributors to disability and dependency in older adults. Current treatments for managing these conditions are limited. Exergaming, a novel technology-driven intervention combining physical exercise with cognitive tasks, is a potential therapeutic approach.", "objectives": "To assess the effects of exergaming interventions on physical and cognitive outcomes, and activities of daily living, in people with dementia and mild cognitive impairment.", "selection criteria": "We included randomised controlled trials (RCTs) that recruited individuals diagnosed with dementia or mild cognitive impairment (MCI). Exergaming interventions involved participants being engaged in physical activity of at least moderate intensity, and used immersive and non-immersive virtual reality (VR) technology and real-time interaction. We planned to classify comparators as inactive control group (e.g. no treatment, waiting list), active control group (e.g. standard treatment, non-specific active control), or alternative treatment (e.g. physical activity, computerised cognitive training). Outcomes were to be measured using validated instruments."}, "labels": ["24452845", "30611286", "31409559", "36745483", "37810620", "28726492", "34032799", "34013018", "33785077", "36824039", "33058735"]}
{"metadata": {"review_pmid": "39254048"}, "inputs": {"background": "In recent years a broader range of immunomodulatory and immunosuppressive treatment options have emerged for people with progressive forms of multiple sclerosis (PMS). While consensus supports these options as reducing relapses, their relative benefit and safety profiles remain unclear due to a lack of direct comparison trials.", "objectives": "To compare through network meta-analysis the efficacy and safety of alemtuzumab, azathioprine, cladribine, cyclophosphamide, daclizumab, dimethylfumarate, diroximel fumarate, fingolimod, fludarabine, glatiramer acetate, immunoglobulins, interferon beta 1-a and beta 1-b, interferon beta-1b (Betaferon), interferon beta-1a (Avonex, Rebif), laquinimod, leflunomide, methotrexate, minocycline, mitoxantrone, mycophenolate mofetil, natalizumab, ocrelizumab, ofatumumab, ozanimod, pegylated interferon beta-1a, ponesimod, rituximab, siponimod, corticosteroids, and teriflunomide for PMS.", "selection criteria": "Randomised controlled trials (RCTs) that studied one or more treatments as monotherapy, compared to placebo or to another active agent, for use in adults with PMS."}, "labels": ["15090564", "32651286", "29545067", "2011253", "32897569", "2668784", "9820296", "33328324", "29576505", "7818255", "19847908", "15451222", "12221157", "31511330", "26827074", "27042677", "12525716", "19797261", "15557491", "30415593", "30844611", "28002688", "30155979", "17623736", "28045953", "11402106", "17262850"]}
{"metadata": {"review_pmid": "39189465"}, "inputs": {"background": "Healthcare workers sometimes develop their own informal solutions to deliver services. One such solution is to use their personal mobile phones or other mobile devices in ways that are unregulated by their workplace. This can help them carry out their work when their workplace lacks functional formal communication and information systems, but it can also lead to new challenges.", "objectives": "To explore the views, experiences, and practices of healthcare workers, managers and other professionals working in healthcare services regarding their informal, innovative uses of mobile devices to support their work.", "selection criteria": "We included qualitative studies and mixed-methods studies with a qualitative component. We included studies that explored healthcare workers' views, experiences, and practices regarding mobile phones and other mobile devices, and that included data about healthcare workers' informal use of these devices for work purposes."}, "labels": ["34568642", "29335160", "27605725", "27697234", "28752519", "34345781", "27273025", "23777890", "27136280", "27476501", "33814676", "33487104", "34345771", "30459525", "25175291", "27925381", "31278013", "30064424", "25298819"]}
{"metadata": {"review_pmid": "39132734"}, "inputs": {"background": "Atopic dermatitis (eczema), can have a significant impact on well-being and quality of life for affected people and their families. Standard treatment is avoidance of triggers or irritants and regular application of emollients and topical steroids or calcineurin inhibitors. Thorough physical and psychological assessment is central to good-quality treatment. Overcoming barriers to provision of holistic treatment in dermatological practice is dependent on evaluation of the efficacy and economics of both psychological and educational interventions in this participant group. This review is based on a previous Cochrane review published in 2014, and now includes adults as well as children.", "objectives": "To assess the clinical outcomes of educational and psychological interventions in children and adults with atopic dermatitis (eczema) and to summarise the availability and principal findings of relevant economic evaluations.", "selection criteria": "Randomised, cluster-randomised and cross-over RCTs that assess educational and psychological interventions for treating eczema in children and adults."}, "labels": ["21236514", "21879233", "1981422", "30141340", "11952543", "11405162", "23458232", "26775779", "17014636", "17506956", "34009282", "16295138", "33486817", "29243849", "11737422", "3778815", "19397561", "27295179", "28940213", "26616256", "29505898", "24942774", "36740888", "22983681", "18304147", "29722071", "12000479", "16627509", "18422535"]}
{"metadata": {"review_pmid": "39105481"}, "inputs": {"background": "Identifying patients with COVID-19 disease who will deteriorate can be useful to assess whether they should receive intensive care, or whether they can be treated in a less intensive way or through outpatient care. In clinical care, routine laboratory markers, such as C-reactive protein, are used to assess a person's health status.", "objectives": "To assess the accuracy of routine blood-based laboratory tests to predict mortality and deterioration to severe or critical (from mild or moderate) COVID-19 in people with SARS-CoV-2.", "selection criteria": "We included studies of all designs that produced estimates of prognostic accuracy in participants who presented to outpatient services, or were admitted to general hospital wards with confirmed SARS-CoV-2 infection, and studies that were based on serum banks of samples from people. All routine blood-based laboratory tests performed during the first encounter were included. We included any reference standard used to define deterioration to severe or critical disease that was provided by the authors."}, "labels": ["32492712", "34754036", "34021028", "33291195", "35686199", "32913691", "35257465", "34926496", "35634446", "32970246", "33280969", "33332691", "33585111", "33497517", "32525548", "33138692", "32407836", "32304772", "33846096", "34697162", "32922185", "32470186", "33070482", "34773859", "32293449", "33660278", "33591234", "34272635", "33282891", "32109013", "34156609", "33810534", "33939271", "34920336", "33467585", "33741750", "34629641", "33380584", "35421418", "35937941", "33323493", "33896114", "33685354", "34613875", "34124411", "34408447", "34042296", "33726485", "32935644", "35407409", "32822413", "32918413", "33637550", "32920232", "32655735", "32376581", "34327110", "34068725", "33336038"]}
{"metadata": {"review_pmid": "39105474"}, "inputs": {"background": "Eczema (atopic dermatitis) is the most burdensome skin condition worldwide and cannot currently be prevented or cured. Topical anti-inflammatory treatments are used to control eczema symptoms, but there is uncertainty about the relative effectiveness and safety of different topical anti-inflammatory treatments.", "objectives": "To compare and rank the efficacy and safety of topical anti-inflammatory treatments for people with eczema using a network meta-analysis.", "selection criteria": "We included within-participant or between-participant randomised controlled trials (RCTs) in people of any age with eczema of any severity, but excluded trials in clinically infected eczema, seborrhoeic eczema, contact eczema, or hand eczema. We included topical anti-inflammatory treatments used for at least one week, compared with another anti-inflammatory treatment, no treatment, or vehicle/placebo. Vehicle is a 'carrier system' for an active pharmaceutical substance, which may also be used on its own as an emollient for dry skin. We excluded trials of topical antibiotics used alone, complementary therapies, emollients used alone, phototherapy, wet wraps, and systemic treatments."}, "labels": ["29154073", "20527137", "732627", "7011356", "4715126", "4611469", "21070333", "18637133", "21150167", "136333", "17298428", "20404242", "22182053", "27423107", "30556911", "31419544", "37054814", "1097198", "9802373", "15898289", "13875579", "13875579", "36808115", "17223872", "11422533", "394140", "16021173", "16021173", "4570340", "4585161", "5000463", "5000463", "31865821", "4099158", "4099158", "20729956", "20729956", "2930221", "2800898", "1684481", "25614148", "19416227", "19563466", "16198779", "14746622", "11907497", "15663667", "18577032", "12456910", "16503881", "11907497", "16546598", "16546598", "352631", "21720655", "1026547", "389843", "17330625", "21637908", "21637908", "34435694", "24942594", "30265585", "4575947", "36824052", "4211138", "7022158", "10489492", "36745371", "37184828", "37184828", "37184828", "17590198", "12174103", "12174103", "28238742", "28164918", "11892051", "11145797", "12271302", "11145793", "12775315", "11145795", "11145794", "11145795", "11145795", "27189825", "6356122", "28193917", "17186796", "17373176", "17373176", "18638631", "18638631", "18638631", "15663667", "12584537", "12456910", "19067708", "15940147", "16798785", "16798785", "17225720", "26623403", "19410693", "19720208", "23571785", "26403410", "7601950", "339846", "12170269", "15539895", "15536429", "16176401", "16436149", "15389185", "18539358", "14522623", "14522623", "26939522", "17373177", "3568065", "35986699", "6357892", "6389385", "10930856", "10487451", "25491116", "4596068", "15446293", "15446293", "19416245", "9071556", "1094657", "11298538", "15204150", "6756798", "797592", "9542676", "6244198", "18380208", "13934420", "15178928", "12399676", "12399676", "20394491", "33150035", "6054003", "1164639", "17935515", "17935515", "28960254", "29665062", "34118298", "31425780", "32029304", "34118298", "34118298", "28823881", "28823881", "32981097", "36811773", "36811773", "34474712", "34474712", "27417017", "32318744", "30345457", "33751495", "34474712", "34474712", "31132182", "31132182", "33728583", "29363715", "36066323", "36113614", "36113614", "36264430", "36574595", "33957195", "36574595", "33957195", "33957195", "36574595", "36574595", "36574595", "36574595", "33957195", "33957195", "33957195", "33957195", "37154471", "26703371", "5291637", "18248495", "2679856", "27080209", "26581111", "31657024", "24085050", "19137769", "15858471", "15858471", "17538803", "20107727", "15858471", "32502588", "30554600", "10799352", "14433742", "4907403", "26329939", "3516754", "31629805", "32057960", "32057960", "11898005", "15030341", "20169301", "20565562", "15948994", "4257091", "348406", "348406", "348406", "11898004", "9295241", "34263481", "31713267", "34289086", "34710557", "33372683", "31483891", "36916653", "34798685", "14496615", "1106945", "16140675", "6342285", "9377615", "6349943", "6373007", "6349943", "6373007", "6349943", "6373007", "6349943", "6373007", "16854753", "18624866", "25802354", "28940181", "4594577", "17573885", "27273433", "26598458", "7947206", "26659931", "26659931", "7030988", "22577263", "8646865", "12953943", "1108858", "20840345", "1778534", "781848", "9681343", "6389217", "2033138", "26163200", "16605293", "16503881", "15569038", "12093983", "24163988", "24163988", "9704834", "21283922", "22834636", "782956", "1757610", "26461821", "18312323", "17911991"]}
{"metadata": {"review_pmid": "39072702"}, "inputs": {"background": "Atrial fibrillation (AF) is an increasingly prevalent heart rhythm condition in adults. It is considered a common cardiovascular condition with complex clinical management. The increasing prevalence and complexity in management underpin the need to adapt and innovate in the delivery of care for people living with AF. There is a need to systematically examine the optimal way in which clinical services are organised to deliver evidence-based care for people with AF. Recommended approaches include collaborative, organised multidisciplinary, and virtual (or eHealth/mHealth) models of care.", "objectives": "To assess the effects of clinical service organisation for AF versus usual care for people with all types of AF.", "selection criteria": "We included randomised controlled trials (RCTs), published as full texts and as abstract only, involving adults (\u2265 18 years) with a diagnosis of any type of AF. We included RCTs comparing organised clinical service, disease-specific management interventions (including e-health models of care) for people with AF that were multicomponent and multidisciplinary in nature to usual care."}, "labels": ["28847546", "31002434", "32241367", "23515338", "22453654", "31390464", "31390464", "24058179", "22453654", "31350778", "36394495", "29531768", "31190590", "25467562", "27083509", "28928175", "32112556", "31544925", "31544925", "35092871"]}
{"metadata": {"review_pmid": "38994714"}, "inputs": {"background": "Cystic echinococcosis is a parasitic infection mainly impacting people living in low- and middle-income countries. Infection may lead to cyst development within organs, pain, non-specific symptoms or complications including abscesses and cyst rupture. Treatment can be difficult and varies by country. Treatments include oral medication, percutaneous techniques and surgery. One Cochrane review previously assessed the benefits and harms of percutaneous treatment compared with other treatments. However, evidence for oral medication, percutaneous techniques and surgery in specific cyst stages has not been systematically investigated and the optimal choice remains uncertain.", "objectives": "To assess the benefits and harms of medication, percutaneous and surgical interventions for treating uncomplicated hepatic cystic echinococcosis.", "selection criteria": "We included randomized controlled trials (RCTs) in people with a diagnosis of uncomplicated hepatic cystic echinococcosis of World Health Organization (WHO) cyst stage CE1, CE2, CE3a or CE3b comparing either oral medication (albendazole) to albendazole plus percutaneous interventions, or to surgery plus albendazole. Studies comparing praziquantel plus albendazole to albendazole alone prior to or following an invasive intervention (surgery or percutaneous treatment) were eligible for inclusion."}, "labels": ["32382859", "35708380"]}
{"metadata": {"review_pmid": "38775255"}, "inputs": {"background": "Sickle cell disease (SCD) refers to a group of genetic disorders characterized by the presence of an abnormal haemoglobin molecule called haemoglobin S (HbS). When subjected to oxidative stress from low oxygen concentrations, HbS molecules form rigid polymers, giving the red cell the typical sickle shape. Antioxidants have been shown to reduce oxidative stress and improve outcomes in other diseases associated with oxidative stress. Therefore, it is important to review and synthesize the available evidence on the effect of antioxidants on the clinical outcomes of people with SCD.", "objectives": "To assess the effectiveness and safety of antioxidant supplementation for improving health outcomes in people with SCD.", "selection criteria": "We included randomized and quasi-randomized controlled trials comparing antioxidant supplementation to placebo, other antioxidants, or different doses of antioxidants, in people with SCD."}, "labels": ["23278176", "18674741", "31764511", "25976467", "23193009", "24095588", "30097463", "22952182", "30853991", "16215013", "11815322", "8713219", "19231043", "20955402", "23645695", "23645695", "34724240", "30021096", "22318468", "22318468", "35426778", "33075179", "12701116", "6388101", "6696358", "6504920", "6347243", "24035168", "4097279", "9308570", "28643376", "28643376", "11434703"]}
{"metadata": {"review_pmid": "38770799"}, "inputs": {"background": "Because of wars, conflicts, persecutions, human rights violations, and humanitarian crises, about 84 million people are forcibly displaced around the world; the great majority of them live in low- and middle-income countries (LMICs). People living in humanitarian settings are affected by a constellation of stressors that threaten their mental health. Psychosocial interventions for people affected by humanitarian crises may be helpful to promote positive aspects of mental health, such as mental well-being, psychosocial functioning, coping, and quality of life. Previous reviews have focused on treatment and mixed promotion and prevention interventions. In this review, we focused on promotion of positive aspects of mental health.", "objectives": "To assess the effects of psychosocial interventions aimed at promoting mental health versus control conditions (no intervention, intervention as usual, or waiting list) in people living in LMICs affected by humanitarian crises.", "selection criteria": "Randomised controlled trials (RCTs) comparing psychosocial interventions versus control conditions (no intervention, intervention as usual, or waiting list) to promote positive aspects of mental health in adults and children living in LMICs affected by humanitarian crises. We excluded studies that enrolled participants based on a positive diagnosis of mental disorder (or based on a proxy of scoring above a cut-off score on a screening measure)."}, "labels": ["30091688", "31574127", "25534065", "11480943", "30782236", "26547145", "32363411", "32408022", "35837815", "24636358", "31314763", "29358120", "28967980", "32582366", "28617937", "30797045"]}
{"metadata": {"review_pmid": "38763518"}, "inputs": {"background": "Prevention of obesity in adolescents is an international public health priority. The prevalence of overweight and obesity is over 25% in North and South America, Australia, most of Europe, and the Gulf region. Interventions that aim to prevent obesity involve strategies that promote healthy diets or 'activity' levels (physical activity, sedentary behaviour and/or sleep) or both, and work by reducing energy intake and/or increasing energy expenditure, respectively. There is uncertainty over which approaches are more effective, and numerous new studies have been published over the last five years since the previous version of this Cochrane Review.", "objectives": "To assess the effects of interventions that aim to prevent obesity in adolescents by modifying dietary intake or 'activity' levels, or a combination of both, on changes in BMI, zBMI score and serious adverse events.", "selection criteria": "Randomised controlled trials in adolescents (mean age 12 years and above but less than 19 years), comparing diet or 'activity' interventions (or both) to prevent obesity with no intervention, usual care, or with another eligible intervention, in any setting. Studies had to measure outcomes at a minimum of 12 weeks post baseline. We excluded interventions designed primarily to improve sporting performance."}, "labels": ["34753667", "16733670", "27102653", "25490946", "29228946", "33655526", "30669291", "26643919", "28111095", "26643919", "15333311", "31518355", "30315116", "28787224", "34775283", "20660556", "24784545", "27244788", "26427719", "23253647", "23157722", "23678500", "21134278", "34087324", "25393601", "25393601", "31091683", "21783046", "33878107", "23506657", "23953358", "22566517", "22566517", "21029467", "22566517", "33978130", "28797704", "16510646", "20617051", "22064878", "17997834", "22692481", "25305637", "21212771", "22591582", "30862118", "17996087", "17803839", "17032704", "16855194", "22156234", "26112041", "26036965", "29695250", "27430652", "23336603", "27549382", "29747047", "24304715", "30203479", "24304715", "26494609", "16458955", "21478377", "19765608", "29251687", "27354070", "35032253", "28793946", "32197342", "24287124", "23594381", "28298396", "26851152", "26248094", "29868390", "29730727", "31122975", "33355155", "26160226", "20800079", "17172199", "18605653", "32917424", "24050416", "26522175", "19781127", "30772298", "27141531", "30932207", "19806417", "24707927", "12799128", "20965379", "30070164", "34761854", "33577117", "23596158", "19470086", "34970862", "20937657", "16118370", "16461867", "19389421", "31267695", "32237995", "32120378", "23672272", "22403695", "20701782", "27693759", "29447248", "17999280", "18055663", "30506696", "16988082", "23440253", "25829124", "31112737", "26153884", "24661535", "19349559", "17548761", "17173701", "25937506", "27430940", "26699231", "27542825", "27844278", "24291151", "25157000", "32242541", "27287848", "30253776", "20375719", "25048788", "22434783", "18302501", "23850014", "23299003", "27075032", "26984117", "29186984", "26655431", "28152232", "25524249", "27768806", "23699748", "29757933", "31718019", "27022997"]}
{"metadata": {"review_pmid": "38763517"}, "inputs": {"background": "Prevention of obesity in children is an international public health priority given the prevalence of the condition (and its significant impact on health, development and well-being). Interventions that aim to prevent obesity involve behavioural change strategies that promote healthy eating or 'activity' levels (physical activity, sedentary behaviour and/or sleep) or both, and work by reducing energy intake and/or increasing energy expenditure, respectively. There is uncertainty over which approaches are more effective and numerous new studies have been published over the last five years, since the previous version of this Cochrane review.", "objectives": "To assess the effects of interventions that aim to prevent obesity in children by modifying dietary intake or 'activity' levels, or a combination of both, on changes in BMI, zBMI score and serious adverse events.", "selection criteria": "Randomised controlled trials in children (mean age 5 years and above but less than 12 years), comparing diet or 'activity' interventions (or both) to prevent obesity with no intervention, usual care, or with another eligible intervention, in any setting. Studies had to measure outcomes at a minimum of 12 weeks post baseline. We excluded interventions designed primarily to improve sporting performance."}, "labels": ["29436364", "29437667", "29437667", "25968599", "31291330", "25212062", "19039880", "27528524", "28052570", "12713209", "12713214", "12713206", "12713207", "12713213", "21146765", "17712126", "25599119", "34599925", "32919383", "31266506", "12713210", "22433612", "22773619", "23168347", "29325517", "31988481", "23150531", "14594792", "27340341", "8267307", "14636805", "30357404", "25891054", "25294064", "33507155", "31364474", "31538954", "19933120", "20585223", "32331366", "33946984", "29850027", "32349761", "22734945", "22215470", "20051087", "23451237", "25323030", "23108477", "26647154", "31449880", "33485354", "35684120", "20113522", "23790990", "25877433", "27040472", "21852659", "22056980", "23335272", "27447721", "22998340", "34746212", "35075816", "19665037", "17611168", "18606013", "27168479", "31488140", "23754782", "11323442", "23819701", "28186099", "22989326", "18381508", "22945605", "20107464", "30339784", "25925226", "26667110", "28578900", "24480729", "28377096", "29624720", "35305674", "33002598", "35227369", "36244610", "34399976", "36531106", "18588706", "19765270", "26217535", "10201726", "25898077", "31826896", "24568125", "25797051", "23379535", "23624466", "34273973", "30786902", "25208853", "32899135", "20107465", "25457793", "29781140", "19623184", "24904696", "19623188", "22430457", "19623187", "22239133", "19623191", "20581420", "24107856", "23294481", "21430121", "21277924", "16128481", "20981151", "27884047", "23624172", "32164691", "32787943", "30207513", "34271077", "30573151", "15107313", "15107313", "17923721", "21609245", "18657280", "23343318", "26305240", "24872892", "19090446", "35329896", "24685956", "28622956", "18252756", "27884840", "24865166", "26801759", "21781344", "23883177", "17588824", "21041593", "22394693", "28222101", "31311060", "27388441", "25328688", "26742063", "21242601", "20179126", "32501613", "24498404", "16756652", "30342255", "33601934", "27855265", "17718785", "25311881", "22381137", "20708496", "29196485", "31770371", "34531712", "35342771", "30565955", "34747972", "31678935", "21398682", "22521298", "28177448", "25483772", "30737048", "27978848", "24980063", "29302609", "28376846", "28807006", "23556434", "27121724", "19142662", "23440308", "25424464", "22456632", "22185086", "35962359", "19290010", "36245531", "25491026", "22410389", "30626597", "30817628", "34919774", "34009010", "24205050", "20697417", "20697417", "24380796", "22099889", "29473237", "34231846", "29648571", "30640483", "26869460", "19920000", "22068444", "30650624", "26700478", "34836156", "31662165", "19806417", "21244862", "22233712", "22308855", "23547765", "25386899", "34633422", "24650843", "33975569", "25680096", "21439049", "30975106", "26795378", "32466678", "33358181", "18180410", "34533295", "22373886", "23592683", "19335890", "21998346", "33477722", "27693759", "29447248", "28511471", "26437939", "31248744", "28780558", "32295569", "12713212", "17600772", "21041592", "23583478", "22690198", "20170502", "20170502", "18194586", "26809555", "23867069", "24743006", "21733268", "23879783", "24643486", "11691758", "11691759", "31890264", "15668218", "18253162", "23688180", "36428089", "21970511", "24124036", "32815644", "24515353", "17908726", "28390403", "34461931", "33846735", "27534742", "31342893", "30215279", "23816490", "30873752", "35294067", "18559131", "28457714", "22092492", "21513530", "30261471", "24509504", "18626482", "18626482", "15543228", "16523185", "16493126", "25251166", "9079575", "12713211", "22513491", "22192795", "33781620", "27737676", "21940922", "21475968", "34444492", "15351759", "27624139", "32857610", "29353440", "17895883", "28978975", "14695360", "25211776", "28177812", "27552276", "30509553", "30851861", "30254362", "21721969", "22402733", "18448393", "24561972", "26510135", "22545755", "32027918", "32678852", "33097026", "33271891", "28917242", "18278626", "19000237", "14627751", "16421350", "15677388", "16385751", "22799482", "27022997"]}
{"metadata": {"review_pmid": "38757544"}, "inputs": {"background": "Global Burden of Disease studies identify hearing loss as the third leading cause of years lived with a disability. Their estimates point to large societal and individual costs from unaddressed hearing difficulties. Workplace noise is an important modifiable risk factor; if addressed, it could significantly reduce the global burden of disease. In practice, providing hearing protection devices (HPDs) is the most common intervention to reduce noise exposure at work. However, lack of fit of HPDs, especially earplugs, can greatly limit their effectiveness. This may be the case for 40% of users. Testing the fit and providing instructions to improve noise attenuation might be effective. In the past two decades, hearing protection fit-test systems have been developed and evaluated in the field. They are called field attenuation estimation systems. They measure the noise attenuation obtained by individual workers using HPDs. If there is a lack of fit, instruction for better fit is provided, and may lead to better noise attenuation obtained by HPDs.", "objectives": "To assess: (1) the effects of field attenuation estimation systems and associated training on the noise attenuation obtained by HPDs compared to no instruction or to less instruction in workers exposed to noise; and (2) whether these interventions promote adherence to HPD use.", "selection criteria": "We included randomised controlled trials (RCTs), cluster-RCTs, controlled before-after studies (CBAs), and interrupted time-series studies (ITSs) exploring HPD fit testing in workers exposed to noise levels of more than 80 A-weighted decibels (or dBA) who use hearing protection devices. The unit 'dBA' reports on the use of a frequency-weighting filter to adjust sound measurement results to better reflect how human ears process sound. The outcome noise attenuation had to be measured either as a personal attenuation rating (PAR), PAR pass rate, or both. PAR pass rate is the percentage of workers who passed a pre-established level of sufficient attenuation from their HPDs, identified on the basis of their individual noise exposure."}, "labels": ["32924674", "25270008"]}
{"metadata": {"review_pmid": "38726883"}, "inputs": {"background": "Magnesium sulphate is a common therapy in perinatal care. Its benefits when given to women at risk of preterm birth for fetal neuroprotection (prevention of cerebral palsy for children) were shown in a 2009 Cochrane review. Internationally, use of magnesium sulphate for preterm cerebral palsy prevention is now recommended practice. As new randomised controlled trials (RCTs) and longer-term follow-up of prior RCTs have since been conducted, this review updates the previously published version.", "objectives": "To assess the effectiveness and safety of magnesium sulphate as a fetal neuroprotective agent when given to women considered to be at risk of preterm birth.", "selection criteria": "We included RCTs and cluster-RCTs of women at risk of preterm birth that assessed prenatal magnesium sulphate for fetal neuroprotection compared with placebo or no treatment. All methods of administration (intravenous, intramuscular, and oral) were eligible. We did not include studies where magnesium sulphate was used with the primary aim of preterm labour tocolysis, or the prevention and/or treatment of eclampsia."}, "labels": ["14645308", "25226476", "22094492", "32383806", "32383806", "37581672", "23570677", "35331677", "24837863", "18166581", "18337147", "17169012", "9388401", "11430960", "12032519", "12066082", "12824976", "15496867", "9699773", "31143877", "21736934", "30112756", "33345890", "26026919", "27245741", "26595801", "26723194", "26723194", "26723194", "28395549", "29433145", "28395549", "26435047", "26254839", "25241107", "25241107", "22056282", "31402735", "27054046", "26036660", "24793722", "24793722", "24858202", "24858202", "24858202", "24858202", "26023905", "25198275", "26116874", "25730227", "25004345", "29631461", "33345968", "26116869", "26058371", "33121885", "32862421", "18753646", "19482114", "27173084", "27177525", "20027029", "20027029", "28612671", "28056569", "29310142", "23016563", "32394601", "32237024", "32427415"]}
{"metadata": {"review_pmid": "38712709"}, "inputs": {"background": "Collaborative care for severe mental illness (SMI) is a community-based intervention that promotes interdisciplinary working across primary and secondary care. Collaborative care interventions aim to improve the physical and/or mental health care of individuals with SMI. This is an update of a 2013 Cochrane review, based on new searches of the literature, which includes an additional seven studies.", "objectives": "To assess the effectiveness of collaborative care approaches in comparison with standard care (or other non-collaborative care interventions) for people with diagnoses of SMI who are living in the community.", "selection criteria": "Randomised controlled trials (RCTs) where interventions described as 'collaborative care' were compared with 'standard care' for adults (18+ years) living in the community with a diagnosis of SMI. SMI was defined as schizophrenia, other types of schizophrenia-like psychosis or bipolar affective disorder. The primary outcomes of interest were: quality of life, mental state and psychiatric admissions at 12 months follow-up."}, "labels": ["19797436", "10074872", "16816277", "16816276", "11903206", "11903206", "18930558", "22340662", "21226970", "24612754", "25462616", "29191136", "23203358", "18586993", "22386799", "23945460", "23945460", "29066976", "26397431", "21849078", "25792695", "25841077"]}
{"metadata": {"review_pmid": "38695628"}, "inputs": {"background": "Respiratory distress occurs in up to 7% of newborns, with respiratory support (RS) provided invasively via an endotracheal (ET) tube or non-invasively via a nasal interface. Invasive ventilation increases the risk of lung injury and chronic lung disease (CLD). Using non-invasive strategies, with or without minimally invasive surfactant, may reduce the need for mechanical ventilation and the risk of lung damage in newborn infants with respiratory distress.", "objectives": "To evaluate the benefits and harms of nasal high-frequency ventilation (nHFV) compared to invasive ventilation via an ET tube or other non-invasive ventilation methods on morbidity and mortality in preterm and term infants with or at risk of respiratory distress.", "selection criteria": "Randomised controlled trials (RCTs), cluster- or quasi-RCTs of nHFV in newborn infants with respiratory distress compared to invasive or non-invasive ventilation."}, "labels": ["30955572", "20963833", "31023363", "31414062", "35935354", "33641473", "30513030", "28904405", "27684415", "27684415", "28904404", "33686823", "33890156", "36862852", "35953535", "29266817", "29064166", "29178630", "28672094", "33827081", "29898763", "31349833", "35467744"]}
{"metadata": {"review_pmid": "38597256"}, "inputs": {"background": "Dengue is a global health problem of high significance, with 3.9 billion people at risk of infection. The geographic expansion of dengue virus (DENV) infection has resulted in increased frequency and severity of the disease, and the number of deaths has increased in recent years. Wolbachia,an intracellular bacterial endosymbiont, has been under investigation for several years as a novel dengue-control strategy. Some dengue vectors (Aedes mosquitoes) can be transinfected with specific strains of Wolbachia, which decreases their fitness (ability to survive and mate) and their ability to reproduce, inhibiting the replication of dengue. Both laboratory and field studies have demonstrated the potential effect of Wolbachia deployments on reducing dengue transmission, and modelling studies have suggested that this may be a self-sustaining strategy for dengue prevention, although long-term effects are yet to be elucidated.", "objectives": "To assess the efficacy of Wolbachia-carrying Aedes speciesdeployments (specifically wMel-, wMelPop-, and wAlbB- strains of Wolbachia) for preventing dengue virus infection.", "selection criteria": "Randomized controlled trials (RCTs), including cluster-randomized controlled trials (cRCTs), conducted in dengue endemic or epidemic-prone settings were eligible. We sought studies that investigated the impact of Wolbachia-carrying Aedes deployments on epidemiological or entomological dengue-related outcomes, utilizing either the population replacement or population suppression strategy."}, "labels": ["32450914", "29855331", "38755197", "35701454", "30226138", "35442957", "34107180"]}
{"metadata": {"review_pmid": "38597126"}, "inputs": {"background": "Midwives are primary providers of care for childbearing women globally and there is a need to establish whether there are differences in effectiveness between midwife continuity of care models and other models of care. This is an update of a review published in 2016.", "objectives": "To compare the effects of midwife continuity of care models with other models of care for childbearing women and their infants.", "selection criteria": "All published and unpublished trials in which pregnant women are randomly allocated to midwife continuity of care models or other models of care during pregnancy and birth."}, "labels": ["22035427", "22035427", "26381076", "12581034", "11251497", "31088505", "33022010", "36634125", "33882059", "2927328", "3194257", "23735597", "8924098", "12473441", "12787235", "11212998", "11080460", "23819882", "34103270", "11215006", "12139908", "11357746", "8494832", "12735413", "23890679", "26841782", "26498455", "22830446", "26498455", "18680606", "11080465", "7565233", "32512314", "28458123", "31231863", "28956168", "24050808", "22029746", "24456576", "10382476", "8684197", "7565154", "11251496", "11592538"]}
{"metadata": {"review_pmid": "38577875"}, "inputs": {"background": "Depression and anxiety occur frequently (with reported prevalence rates of around 40%) in individuals with coronary heart disease (CHD), heart failure (HF) or atrial fibrillation (AF) and are associated with a poor prognosis, such as decreased health-related quality of life (HRQoL), and increased morbidity and mortality. Psychological interventions are developed and delivered by psychologists or specifically trained healthcare workers and commonly include cognitive behavioural therapies and mindfulness-based stress reduction. They have been shown to reduce depression and anxiety in the general population, though the exact mechanism of action is not well understood. Further, their effects on psychological and clinical outcomes in patients with CHD, HF or AF are unclear.", "objectives": "To assess the effects of psychological interventions (alone, or with cardiac rehabilitation or pharmacotherapy, or both) in adults who have a diagnosis of CHD, HF or AF, compared to no psychological intervention, on psychological and clinical outcomes.", "selection criteria": "We included randomised controlled trials (RCTs) comparing psychological interventions with no psychological intervention for a minimum of six months follow-up in adults aged over 18 years with a clinical diagnosis of CHD, HF or AF, with or without depression or anxiety. Studies had to report on either depression or anxiety or both."}, "labels": ["22555264", "26406475", "26406475", "29482218", "23828185", "21960653", "31960537", "20410252", "20386003", "19349308", "20624510", "28192003", "25264974", "20030843", "34028358", "26733462", "26733462", "31804580", "21349204", "25159700", "24570217", "19426524", "22956633", "32791501", "29856312", "29609644", "26830029", "23595004", "23147275", "29615092", "34148379", "35722590", "35467904", "20041881"]}
{"metadata": {"review_pmid": "38533994"}, "inputs": {"background": "Cardiovascular diseases (CVDs) are the leading cause of death globally, accounting for almost 18 million deaths annually. People with CVDs have a five times greater chance of suffering a recurrent cardiovascular event than people without known CVDs. Although drug interventions have been shown to be cost-effective in reducing the risk of recurrent cardiovascular events, adherence to medication remains suboptimal. As a scalable and cost-effective approach, mobile phone text messaging presents an opportunity to convey health information, deliver electronic reminders, and encourage behaviour change. However, it is uncertain whether text messaging can improve medication adherence and clinical outcomes. This is an update of a Cochrane review published in 2017.", "objectives": "To evaluate the benefits and harms of mobile phone text messaging for improving medication adherence in people with CVDs compared to usual care.", "selection criteria": "We included randomised controlled trials (RCTs) with participants with established arterial occlusive events. We included trials investigating interventions using short message service (SMS) or multimedia messaging service (MMS) with the aim of improving adherence to medication for the secondary prevention of cardiovascular events. The comparator was usual care. We excluded cluster-RCTs and quasi-RCTs."}, "labels": ["34559058", "34319247", "31818831", "30478888", "26393848", "22267690", "27741244", "27512051", "35533220", "29374674", "24588893", "26490012", "26522838", "31474119", "26311325", "26486857", "24491349", "34106081", "29370829", "35262490", "28778843", "24321403", "24321403", "24853566", "31145281", "23462636", "33988519", "28536088", "29273661", "30998400"]}
{"metadata": {"review_pmid": "38511668"}, "inputs": {"background": "Active case finding (ACF) refers to the systematic identification of people with tuberculosis in communities and amongst populations who do not present to health facilities, through approaches such as door-to-door screening or contact tracing. ACF may improve access to tuberculosis diagnosis and treatment for the poor and for people remote from diagnostic and treatment facilities. As a result, ACF may also reduce onward transmission. However, there is a need to understand how these programmes are experienced by communities in order to design appropriate services.", "objectives": "To synthesize community views on tuberculosis active case finding (ACF) programmes in low- and middle-income countries.", "selection criteria": "This review synthesized qualitative research and mixed-methods studies with separate qualitative data. Eligible studies explored community experiences, perceptions, or attitudes towards ACF programmes for tuberculosis in any endemic low- or middle-income country, with no time restrictions."}, "labels": ["35924619", "37100574", "30236182", "28274245", "33794878", "34011353", "35346094", "34564551", "34388206", "26459524", "35305634", "36922792", "31683801", "32042606", "31550905", "31895932", "32414819", "37167225", "34014956", "36918800", "28558737", "34574579", "31345194", "26222545", "28886072", "29226096", "33289194", "30092865", "24073277", "31439112", "30963038", "31954279", "31887995", "36828509", "33557831", "32615942", "32047666", "28082666", "32442201", "22640446", "25885789", "31265458", "35148800", "30442637"]}
{"metadata": {"review_pmid": "38441440"}, "inputs": {"background": "People with cancer are 1.4 times more likely to be unemployed than people without a cancer diagnosis. Therefore, it is important to investigate whether programmes to enhance the return-to-work (RTW) process for people who have been diagnosed with cancer are effective. This is an update of a Cochrane review first published in 2011 and updated in 2015.", "objectives": "To evaluate the effectiveness of non-medical interventions aimed at enhancing return to work (RTW) in people with cancer compared to alternative programmes including usual care or no intervention.", "selection criteria": "We included randomised controlled trials (RCTs) and cluster-RCTs on the effectiveness of psycho-educational, vocational, physical or multidisciplinary interventions enhancing RTW in people with cancer. The primary outcome was RTW measured as either RTW rate or sick leave duration measured at 12 months' follow-up. The secondary outcome was quality of life (QoL)."}, "labels": ["7880598", "16406909", "34289828", "30670507", "28599338", "23768153", "30247961", "14570527", "6362943", "30912010", "20694822", "29270828", "23717406", "30778742", "25918291", "32880094"]}
{"metadata": {"review_pmid": "38438116"}, "inputs": {"background": "Admission avoidance hospital at home provides active treatment by healthcare professionals in the patient's home for a condition that would otherwise require acute hospital inpatient care, and always for a limited time period. This is the fourth update of this review.", "objectives": "To determine the effectiveness and cost of managing patients with admission avoidance hospital at home compared with inpatient hospital care.", "selection criteria": "Randomised controlled trials recruiting participants aged 18 years and over. Studies comparing admission avoidance hospital at home with acute hospital inpatient care."}, "labels": ["10937409", "16127109", "10078179", "15604157", "11082090", "30948606", "29680821", "16053592", "11036894", "14684783", "29411238", "31842232", "33479931", "19875400", "11842709", "14728641", "18179503", "16138795", "30340618", "33872045", "29061154", "34969074", "21931037", "21931024", "15207444", "19786675", "23696687", "10591720", "10591717", "11791829"]}
{"metadata": {"review_pmid": "38438114"}, "inputs": {"background": "Worldwide there is an increasing demand for Hospital at Home as an alternative to hospital admission. Although there is a growing evidence base on the effectiveness and cost-effectiveness of Hospital at Home, health service managers, health professionals and policy makers require evidence on how to implement and sustain these services on a wider scale.", "objectives": "(1) To identify, appraise and synthesise qualitative research evidence on the factors that influence the implementation of Admission Avoidance Hospital at Home and Early Discharge Hospital at Home, from the perspective of multiple stakeholders, including policy makers, health service managers, health professionals, patients and patients' caregivers. (2) To explore how our synthesis findings relate to, and help to explain, the findings of the Cochrane intervention reviews of Admission Avoidance Hospital at Home and Early Discharge Hospital at Home services.", "selection criteria": "We included qualitative studies and mixed-methods studies with qualitative data collection and analysis methods examining the implementation of new or existing Hospital at Home services from the perspective of different stakeholders."}, "labels": ["24015469", "29115811", "30735244", "21113847", "26414034", "24006226", "20142405", "23455948", "21679228", "15082429", "17577401", "17627299", "18230417", "30948606", "17453984", "17470039", "11233588", "35895746", "31196123", "36197021", "32579574", "12519245", "34395696", "33241649", "36008593", "34541725", "17705866", "28155754", "33479931", "27481568", "30340618", "32428202", "29061154", "27715257", "26572860", "23800106", "27327142", "30595783", "34617613", "31288804", "16157339", "34162385", "34389578", "35977148", "31871725", "33534426", "11128731", "9793750", "36001608", "22920051", "11791829"]}
{"metadata": {"review_pmid": "38426600"}, "inputs": {"background": "The number of older people is increasing worldwide and public expenditure on residential aged care facilities (ACFs) is expected to at least double, and possibly triple, by 2050. Co-ordinated and timely care in residential ACFs that reduces unnecessary hospital transfers may improve residents' health outcomes and increase satisfaction with care among ACF residents, their families and staff. These benefits may outweigh the resources needed to sustain the changes in care delivery and potentially lead to cost savings. Our systematic review comprehensively and systematically presents the available evidence of the effectiveness, safety and cost-effectiveness of alternative models of providing health care to ACF residents.", "objectives": "Main objective To assess the effectiveness and safety of alternative models of delivering primary or secondary health care (or both) to older adults living in ACFs. Secondary objective To assess the cost-effectiveness of the alternative models.", "selection criteria": "We included individual and cluster-randomised trials, and cost/cost-effectiveness data collected alongside eligible effectiveness studies. Eligible study participants included older people who reside in an ACF as their place of permanent abode and healthcare professionals delivering or co-ordinating the delivery of healthcare at ACFs. Eligible interventions focused on either ways of delivering primary or secondary health care (or both) or ways of co-ordinating the delivery of this care. Eligible comparators included usual care or another model of care. Primary outcomes were emergency department visits, unplanned hospital admissions and adverse effects (defined as infections, falls and pressure ulcers). Secondary outcomes included adherence to clinical guideline-recommended care, health-related quality of life of residents, mortality, resource use, access to primary or specialist healthcare services, any hospital admissions, length of hospital stay, satisfaction with the health care by residents and their families, work-related satisfaction and work-related stress of ACF staff."}, "labels": ["26589957", "28786995", "29753297", "23972906", "18179497", "21708967", "18606020", "22655047", "25283552", "12590626", "8307806", "18232242", "25239019", "29396192", "15385274", "30794284", "32272888", "26420423", "23758078", "31894731", "31681981", "24493767", "32237279", "35317785", "24735110", "32668005", "28506247", "28420324", "33079474", "16252379", "16869334", "21599894", "22521629", "23643110", "31948507", "23992241", "29669442", "27406242", "28669575", "20171451", "25019632", "16150741", "16757722", "30477548", "32075817", "22344753", "19221130", "29892989", "21435251", "26804064", "27299496", "30220897", "28142397", "2115755", "34896069", "32912192", "24559218", "29068904", "18713215", "32646823", "31856882", "29530091", "31710345", "32957971", "19520440", "26420646", "25458804", "25059544", "24878214", "21338502"]}
{"metadata": {"review_pmid": "38421211"}, "inputs": {"background": "Choosing an optimal reconstruction method is pivotal for patients with gastric cancer undergoing distal gastrectomy. The uncut Roux-en-Y reconstruction, a variant of the conventional Roux-en-Y approach (or variant of the Billroth II reconstruction), employs uncut devices to occlude the afferent loop of the jejunum. This modification is designed to mitigate postgastrectomy syndrome and enhance long-term functional outcomes. However, the comparative benefits and potential harms of this approach compared to other reconstruction techniques remain a topic of debate.", "objectives": "To assess the benefits and harms of uncut Roux-en-Y reconstruction after distal gastrectomy in patients with gastric cancer.", "selection criteria": "We included randomised controlled trials (RCTs) and quasi-RCTs comparing uncut Roux-en-Y reconstruction versus other reconstructions after distal gastrectomy for gastric cancer. The comparison groups encompassed other reconstructions such as Billroth I, Billroth II (with or without Braun anastomosis), and Roux-en-Y reconstruction."}, "labels": ["11036137", "32556870", "30863178", "36917403", "37160808", "28974902"]}
{"metadata": {"review_pmid": "38415871"}, "inputs": {"background": "Adolescent idiopathic scoliosis (AIS) is a pathology that changes the three-dimensional shape of the spine and trunk. While AIS can progress during growth and cause cosmetic issues, it is usually asymptomatic. However, a final spinal curvature above the critical threshold of 30\u00b0 increases the risk of health problems and curve progression in adulthood. The use of therapeutic exercises (TEs) to reduce the progression of AIS and delay or avoid other, more invasive treatments is still controversial.", "objectives": "To evaluate the effectiveness of TE, including generic therapeutic exercises (GTE) and physiotherapeutic scoliosis-specific exercises (PSSE) in treating AIS, compared to no treatment, other non-surgical treatments, or between treatments.", "selection criteria": "Randomised controlled trials (RCTs) comparing TE with no treatment, other non-surgical treatments (braces, electrical stimulation, manual therapy), and different types of exercises. In the previous version of the review, we also included observational studies. We did not include observational studies in this update since we found sufficient RCTs to address our study aims."}, "labels": ["350002", "24945482", "31318743", "27134403", "33857180", "25780260", "24682356", "35958375", "25439713", "28033399", "26413145", "28885287"]}
{"metadata": {"review_pmid": "38415846"}, "inputs": {"background": "Oral submucous fibrosis (OSF) is a chronic disease of the oral cavity that causes progressive constriction of the cheeks and mouth accompanied by severe pain and reduced mouth opening. OSF has a significant impact on eating and swallowing, affecting quality of life. There is an increased risk of oral malignancy in people with OSF. The main risk factor for OSF is areca nut chewing, and the mainstay of treatment has been behavioural interventions to support habit cessation. This review is an update of a version last published in 2008.", "objectives": "To evaluate the benefits and harms of interventions for the management of oral submucous fibrosis.", "selection criteria": "We considered randomised controlled trials (RCTs) of adults with a biopsy-confirmed diagnosis of OSF treated with systemic, locally delivered or topical drugs at any dosage, duration or delivery method compared against placebo or each other. We considered surgical procedures compared against other treatments or no active intervention. We also considered other interventions such as physiotherapy, ultrasound or alternative therapies."}, "labels": ["26337213", "32652683", "22893038", "18673417", "30693888", "25879347", "23260769", "38911420", "38911420", "17234537", "21790236", "24551724", "25136428", "26148587", "25853042", "28717289", "30059188", "25729231", "33576219", "17217216", "20516538", "27891454", "22650317", "25891654", "31249773", "20448359", "25737939"]}
{"metadata": {"review_pmid": "38415786"}, "inputs": {"background": "Massage is widely used for neck pain, but its effectiveness remains unclear.", "objectives": "To assess the benefits and harms of massage compared to placebo or sham, no treatment or exercise as an adjuvant to the same co-intervention for acute to chronic persisting neck pain in adults with or without radiculopathy, including whiplash-associated disorders and cervicogenic headache.", "selection criteria": "We included randomised controlled trials (RCTs) comparing any type of massage with sham or placebo, no treatment or wait-list, or massage as an adjuvant treatment, in adults with acute, subacute or chronic neck pain."}, "labels": ["31511705", "24405830", "19066648", "34092587", "26211422", "30202408", "26340656", "11431299", "29037651", "31815684", "30588067", "33296258", "23374199", "20953433", "21655422", "29072931", "30931028", "30858662", "26746173", "26096474", "24615306", "31989965", "26377322", "31655314", "33431282"]}
{"metadata": {"review_pmid": "38411279"}, "inputs": {"background": "Management of congenital hemophilia A and B is by prophylactic or on-demand replacement therapy with clotting factor concentrates. The effects of newer non-clotting factor therapies such as emicizumab, concizumab, marstacimab, and fitusiran compared with existing standards of care are yet to be systematically reviewed.", "objectives": "To assess the effects (clinical, economic, patient-reported, and adverse outcomes) of non-clotting factor therapies for preventing bleeding and bleeding-related complications in people with congenital hemophilia A or B compared with prophylaxis with clotting factor therapies, bypassing agents, placebo, or no prophylaxis.", "selection criteria": "Randomized controlled trials (RCTs) evaluating people with congenital hemophilia A or B with and without inhibitors, who were treated with non-clotting factor therapies to prevent bleeds."}, "labels": ["37003278", "37003287", "31444162", "35290453", "37646676", "33512413", "31124272", "30427582", "30427582", "28691557", "33086400", "34171159", "33512413", "32253943", "33506955", "35905294", "33664606", "30157389", "30157389", "31355677", "31355677", "31355677", "31355677", "34171159", "34171159"]}
{"metadata": {"review_pmid": "38411248"}, "inputs": {"background": "Cystic fibrosis (CF) is a life-limiting genetic condition, affecting over 90,000 people worldwide. CF affects several organs in the body, but airway damage has the most profound impact on quality of life (QoL) and survival. Causes of lower airway infection in people with CF are, most notably, Staphylococcus aureus in the early course of the disease and Pseudomonas aeruginosa at a later stage. Macrolide antibiotics, e.g. azithromycin and clarithromycin, are usually taken orally, have a broad spectrum of action against gram-positive (e.g. S aureus) and some gram-negative bacteria (e.g. Haemophilus influenzae), and may have a modifying role in diseases involving airway infection and inflammation such as CF. They are well-tolerated and relatively inexpensive, but widespread use has resulted in the emergence of resistant bacteria. This is an updated review.", "objectives": "To assess the potential effects of macrolide antibiotics on clinical status in terms of benefit and harm in people with CF. If benefit was demonstrated, we aimed to assess the optimal type, dose and duration of macrolide therapy.", "selection criteria": "We included randomised controlled trials of macrolide antibiotics in adults and children with CF. We compared them to: placebo; another class of antibiotic; another macrolide antibiotic; or the same macrolide antibiotic at a different dose or type of administration."}, "labels": ["16809416", "35662406", "12383667", "12383667", "19818694", "17537764", "34706982", "33246911", "29890086", "30874457", "29967580", "16096858", "17469154", "17469154", "14519709", "16040785", "31201785", "21543567", "23770109", "22595153", "20442386", "20442386", "22684984", "18701270", "14679744", "11867823"]}
{"metadata": {"review_pmid": "38375882"}, "inputs": {"background": "Obesity is considered to be a risk factor for various diseases, and its incidence has tripled worldwide since 1975. In addition to potentially being at risk for adverse health outcomes, people with overweight or obesity are often stigmatised. Behaviour change interventions are increasingly delivered as mobile health (m-health) interventions, using smartphone apps and wearables. They are believed to support healthy behaviours at the individual level in a low-threshold manner.", "objectives": "To assess the effects of integrated smartphone applications for adolescents and adults with overweight or obesity.", "selection criteria": "Participants were adolescents and adults with overweight or obesity. Eligible interventions were integrated smartphone apps using at least two behaviour change techniques. The intervention could target physical activity, cardiorespiratory fitness, weight loss, healthy diet, or self-efficacy. Comparators included no or minimal intervention (NMI), a different smartphone app, personal coaching, or usual care. Eligible studies were randomised controlled trials of any duration with a follow-up of at least three months."}, "labels": ["31093681", "24462568", "24462568", "30341051", "26229119", "26530929", "26530929", "28153814", "23587561", "28566263", "32713290", "32003750", "34407782", "32295776", "36432446", "35103609", "33242020", "35057451", "29480874", "29543184", "29326093", "30576840", "35794781", "32130198", "36673756", "31094352", "34243738", "35285809", "34124856", "32804087", "36364870", "35956348", "37140392", "26646593", "30038502", "34868619", "31038464", "33826861", "30654026", "36484235", "35006001", "36641335"]}
{"metadata": {"review_pmid": "38372447"}, "inputs": {"background": "Infliximab is a monoclonal antibody that binds and neutralises tumour necrosis factor-alpha (TNF-\u03b1) which is present in high levels in the blood serum, mucosa and stool of patients with Crohn's disease.", "objectives": "To determine the efficacy and safety of infliximab for maintaining remission in patients with Crohn's disease.", "selection criteria": "Randomised controlled trials (RCTs) in which infliximab was compared to placebo or another active comparator for maintenance, remission, or response in patients with Crohn's disease."}, "labels": ["38319804", "25524543", "14572573", "12047962", "16307694", "15224278", "32965617", "28502609", "36640794", "10500056", "15825070", "14985485", "33676969", "21948942", "34013959"]}
{"metadata": {"review_pmid": "38358047"}, "inputs": {"background": "Interventions incorporating meditation to address stress, anxiety, and depression, and improve self-management, are becoming popular for many health conditions. Stress is a risk factor for cardiovascular disease (CVD) and clusters with other modifiable behavioural risk factors, such as smoking. Meditation may therefore be a useful CVD prevention strategy.", "objectives": "To determine the effectiveness of meditation, primarily mindfulness-based interventions (MBIs) and transcendental meditation (TM), for the primary and secondary prevention of CVD.", "selection criteria": "We included randomised controlled trials (RCTs) of 12 weeks or more in adults at high risk of CVD and those with established CVD. We explored four comparisons: MBIs versus active comparators (alternative interventions); MBIs versus non-active comparators (no intervention, wait list, usual care); TM versus active comparators; TM versus non-active comparators."}, "labels": ["32099857", "34136657", "29984258", "30940047", "24038797", "24038797", "22396225", "31529385", "21723049", "28985151", "27670865", "32192020", "32103635", "33428638", "27903561", "21977314", "22169588", "26955895", "29901486", "24957302", "24611852", "34222059", "25407688", "27335319", "27261988", "27261988", "29917096", "25884648", "32723722", "34741544", "6756484", "27698102", "32536026", "31011624", "29542299", "22338101", "24798861", "24798861", "29493266", "23102183", "23102183", "23855018", "32642486", "29263572", "26697087", "19798037", "31804580", "33457344", "28119138", "23930029", "16772250", "30425326", "30425326", "25662105", "28686006", "21621733", "27912933", "33707393", "8707387", "15691622", "7591024", "23149426", "10700487", "11763829", "31641325", "34729544", "6995617", "34064218", "29755221", "29211681", "25566369", "24898301", "28662208", "25832365", "23788695", "23788695", "27212669", "23193218", "21349184", "24913347", "28650195", "27213492", "32222767", "33069106", "31511777", "32550181"]}
{"metadata": {"review_pmid": "38357958"}, "inputs": {"background": "Stimulant use disorder is a continuously growing medical and social burden without approved medications available for its treatment. Psychosocial interventions could be a valid approach to help people reduce or cease stimulant consumption. This is an update of a Cochrane review first published in 2016.", "objectives": "To assess the efficacy and safety of psychosocial interventions for stimulant use disorder in adults.", "selection criteria": "We included randomised controlled trials (RCTs) comparing any psychosocial intervention with no intervention, treatment as usual (TAU), or a different intervention in adults with stimulant use disorder."}, "labels": ["30835643", "11672492", "15733250", "27177805", "1928019", "7714514", "8122955", "7979888", "11048353", "9692270", "14993114", "22695473", "18450927", "19041197", "24577287", "25461789", "26817621", "29286595", "14692007", "10359461", "9283507", "17446974", "9788001", "15664719", "18463998", "10359461", "23277248", "24746956", "21447950", "21838845", "17295995", "19586227", "17512158", "18068905", "19192858", "17907858", "23453480", "8480823", "8031230", "10710841", "14557150", "21306837", "9803694", "16893278", "25884003", "16310974", "16771893", "29696218", "29478874", "9803702", "23138961", "17573205", "21172026", "27442691", "29251975", "34619447", "17512156", "19833998", "30045702", "30887824", "17172773", "29536284", "16461864", "25456571", "19152207", "16203960", "15796645", "18085914", "22250852", "22229758", "23182410", "25198284", "30265039", "28070254", "16461866", "12495796", "12215081", "12495796", "12495796", "12495796", "23708468", "21355914", "21454024", "22999380", "17563217", "15845315", "15845315", "15845315", "18329226", "8624184", "9803700", "20408061", "33413631", "18657938"]}
{"metadata": {"review_pmid": "38353936"}, "inputs": {"background": "Patients who present with problems with definitive dialysis access (arteriovenous fistula (AVF) or arteriovenous graft (AVG)) become catheter dependent (temporary access), a condition that often carries a higher risk of infections, central venous occlusions and recurrent hospitalisations. For AVG, primary patency rates are reported to be 30% to 90% in patients undergoing thrombectomy or thrombolysis. According to the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) guidelines, surgery is preferred when the cause of the thrombosis is a stenosis at the site of the anastomosis in thrombosed AVF. The European Best Practice Guidelines (EBPG) reported that thrombosed AVF may be preferably treated with endovascular techniques, but when the cause of thrombosis is in the anastomosis, surgery provides better results with re-anastomosis. Therefore, there is a need to carry out a systematic review to determine the effectiveness and safety of the intervention for thrombosed fistulae.", "objectives": "This review aims to establish the efficacy and safety of interventions for failed AVF and AVG in patients receiving haemodialysis (HD).", "selection criteria": "The review included randomised controlled trials (RCTs) and quasi-RCTs in people undergoing HD treatment using AVF or AVG presenting with clinical or haemodynamic evidence of thrombosis. Patients had to have used an AVF or AVG at least once."}, "labels": ["11110928", "8072252", "10540659", "10587385", "9502680", "11054238", "9510303", "9719343", "9308583", "9719342", "8185029", "9457193", "9007796", "15503036", "8855526", "10527197", "11585881"]}
{"metadata": {"review_pmid": "38353301"}, "inputs": {"background": "Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) causes progressive or relapsing weakness and numbness of the limbs, which lasts for at least two months. Uncontrolled studies have suggested that intravenous immunoglobulin (IVIg) could help to reduce symptoms. This is an update of a review first published in 2002 and last updated in 2013.", "objectives": "To assess the efficacy and safety of intravenous immunoglobulin in people with chronic inflammatory demyelinating polyradiculoneuropathy.", "selection criteria": "We selected randomised controlled trials (RCTs) and quasi-RCTs that tested any dose of IVIg versus placebo, plasma exchange, or corticosteroids in people with definite or probable CIDP."}, "labels": ["7998769", "8813271", "11506402", "18178525", "11222785", "22578914", "8936360", "8429321"]}
{"metadata": {"review_pmid": "38353289"}, "inputs": {"background": "Variation in blood pressure levels display circadian rhythms. Complete 24-hour blood pressure control is the primary goal of antihypertensive treatment and reducing adverse cardiovascular outcomes is the ultimate aim. This is an update of the review first published in 2011.", "objectives": "To evaluate the effectiveness of administration-time-related effects of once-daily evening versus conventional morning dosing antihypertensive drug therapy regimens on all-cause mortality, cardiovascular mortality and morbidity, total adverse events, withdrawals from treatment due to adverse effects, and reduction of systolic and diastolic blood pressure in people with primary hypertension.", "selection criteria": "We included randomised controlled trials (RCTs) comparing the administration-time-related effects of evening with morning dosing monotherapy regimens in people with primary hypertension. We excluded people with known secondary hypertension, shift workers or people with white coat hypertension."}, "labels": ["22024668", "8085776", "17198647", "12517683", "12874091", "15332347", "16147905", "16148616", "17612946", "17635851", "18600215", "19005898", "19142758", "19433778", "19543080", "34912861", "1295122", "9469797", "16015049", "10212327", "1330398", "1575169", "9557932", "14618095", "10480474", "25259546"]}
{"metadata": {"review_pmid": "38353263"}, "inputs": {"background": "Peripheral arterial disease (PAD) is the obstruction or narrowing of the large arteries of the lower limbs, which can result in impaired oxygen supply to the muscle and other tissues during exercise, or even at rest in more severe cases. PAD is classified into five categories (Fontaine classification). It may be asymptomatic or various levels of claudication pain may be present; at a later stage, there may be ulceration or gangrene of the limb, with amputation occasionally being required. About 20% of people with PAD suffer from intermittent claudication (IC), which is muscular discomfort in the lower extremities induced by exertion and relieved by rest within 10 minutes; IC causes restriction of movement in daily life. Treatment for people with IC involves addressing lifestyle risk factors. Exercise is an important part of treatment, but supervised exercise programmes for individuals with IC have low engagement levels and high attrition rates. The use of mobile technologies has been suggested as a new way to engage people with IC in walking exercise interventions. The novelty of the intervention, low cost for the user, automation, and ease of access are some of the advantages mobile health (mhealth) technologies provide that give them the potential to be effective in boosting physical activity in adults.", "objectives": "To assess the benefits and harms of mobile health (mhealth) technologies to improve walking distance in people with intermittent claudication.", "selection criteria": "We included randomised controlled trials (RCTs) in people aged 18 years or over with symptomatic PAD and a clinical diagnosis of IC. We included RCTs comparing mhealth interventions to improve walking distance versus usual care (no intervention or non-exercise advice), exercise advice, or supervised exercise programmes. We excluded people with chronic limb-threatening ischaemia (Fontaine III and IV)."}, "labels": ["30049464", "21262997", "29710165", "33821898"]}
{"metadata": {"review_pmid": "38348930"}, "inputs": {"background": "Infants born preterm are at increased risk of cognitive and motor impairments compared with infants born at term. Early developmental interventions for preterm infants are targeted at the infant or the parent-infant relationship, or both, and may focus on different aspects of early development. They aim to improve developmental outcomes for these infants, but the long-term benefits remain unclear. This is an update of a Cochrane review first published in 2007 and updated in 2012 and 2015.", "objectives": "Primary objective To assess the effect of early developmental interventions compared with standard care in prevention of motor or cognitive impairment for preterm infants in infancy (zero to < three years), preschool age (three to < five years), and school age (five to < 18 years). Secondary objective To assess the effect of early developmental interventions compared with standard care on motor or cognitive impairment for subgroups of preterm infants, including groups based on gestational age, birthweight, brain injury, timing or focus of intervention and study quality.", "selection criteria": "Studies included randomised, quasi-randomised controlled trials (RCTs) or cluster-randomised trials of early developmental intervention programmes that began within the first 12 months of life for infants born before 37 weeks' gestational age (GA). Interventions could commence as an inpatient but had to include a post discharge component for inclusion in this review. Outcome measures were not prespecified, other than that they had to assess cognitive outcomes, motor outcomes or both. The control groups in the studies could receive standard care that would normally be provided."}, "labels": ["37191836", "37534617", "9797618", "15899921", "11605609", "2433310", "3948591", "16357661", "26397087", "22543889", "27449367", "25884634", "30857773", "26102168", "29426320", "33827496", "7398450", "33137579", "16530990", "2415788", "1881735", "9579002", "7779349", "7687948", "1538279", "7933370", "9866087", "8990337", "16510657", "9809269", "7692028", "2188023", "19595367", "25249191", "17698301", "20937650", "31056541", "18783797", "19880139", "26936312", "23312690", "21784445", "23063851", "11552873", "29262939", "11746067", "30965355", "11453445", "7677972", "2083491", "6736497", "2454783", "2318015", "35740832", "15569286", "34293634", "2452838", "518980", "11469284", "12490052", "10048099", "25319764", "28328946", "23129084", "20547650", "27940686", "19954550", "29058313", "35304169", "36130917", "24973546", "12405434", "33946995", "36409665", "33047325"]}
{"metadata": {"review_pmid": "38348912"}, "inputs": {"background": "Abortions prior to 14 weeks are among the most common outpatient surgical procedures performed on people capable of becoming pregnant. Various methods have been used to control pain; however, many people still experience pain with the procedure.", "objectives": "To evaluate the benefits and harms of local anaesthesia given for pain control during surgical abortion at less than 14 weeks' gestation.", "selection criteria": "We selected effectiveness and comparative effectiveness randomized controlled trials that studied local anaesthesia with common local anaesthetics and administration routes given for pain control in surgical abortion at less than 14 weeks' gestation using uterine aspiration. Outcomes included intraoperative pain, patient satisfaction, and adverse events."}, "labels": ["24455735", "26926158", "26926158", "19803123", "9243192", "33196038", "11166751", "16478762", "12066113", "22525915", "27235677", "27235677", "1442914", "7556858", "8910086"]}
{"metadata": {"review_pmid": "38345088"}, "inputs": {"background": "Pressure ulcers are localized injuries to the skin or the underlying tissue, or both, and are common in older and immobile people, people with diabetes, vascular disease, or malnutrition, as well as those who require intensive or palliative care. People with pressure ulcers often suffer from severe pain and exhibit social avoidance behaviours. The prevention and treatment of pressure ulcers involves strategies to optimize hydration, circulation, and nutrition. Adequate nutrient intake can reduce the risk factor of malnutrition and promote wound healing in existing pressure ulcers. However, it is unclear which nutrients help prevent and treat pressure ulcers. This is an update of an earlier Cochrane Review.", "objectives": "To evaluate the benefits and harms of nutritional interventions (special diets, supplements) for preventing and treating pressure ulcers in people with or without existing pressure ulcers compared to standard diet or other nutritional interventions.", "selection criteria": "We included randomized controlled trials (RCTs) in people with or without existing pressure ulcers, that compared nutritional interventions aimed at preventing or treating pressure ulcers with standard diet or other types of nutritional interventions."}, "labels": ["23642400", "18604321", "27410392", "11431045", "18407904", "10674226", "4887340", "19563522", "19563522", "26703983", "26703983", "25643304", "26666797", "9646297", "15733716", "16297506", "16839927", "16837353", "10205352", "12880608", "12880608", "16557055", "22399084", "19621198", "23979345", "21539650", "25324332", "30061579", "4140267", "8543959", "17933438", "22751375", "22040465", "22040465", "20598855", "24810310"]}
{"metadata": {"review_pmid": "38345071"}, "inputs": {"background": "Acute and chronic postoperative pain are important healthcare problems, which can be treated with a combination of opioids and regional anaesthesia. The erector spinae plane block (ESPB) is a new regional anaesthesia technique, which might be able to reduce opioid consumption and related side effects.", "objectives": "To compare the analgesic effects and side effect profile of ESPB against no block, placebo block or other regional anaesthetic techniques.", "selection criteria": "Randomised controlled trials (RCTs) investigating adults undergoing surgery with general anaesthesia were included. We included ESPB in comparison with no block, placebo blocks or other regional anaesthesia techniques irrespective of language, publication year, publication status or technique of regional anaesthesia used (ultrasound, landmarks or peripheral nerve stimulator). Quasi-RCTs, cluster-RCTs, cross-over trials and studies investigating co-interventions in either arm were excluded."}, "labels": ["32449336", "30801359", "31736025", "30851501", "30396100", "31862217", "31330457", "33155041", "32956890", "31122843", "32417925", "31879425", "33209056", "32955601", "31168455", "32660716", "32144056", "33031265", "30930141", "31198256", "31880963", "29980005", "31280100", "31118757", "31620856", "32843804", "32709172", "31649028", "30055991", "32886200", "33295128", "30052229", "30535555", "33380573", "33447190", "32171499", "31998015", "32317873", "32944329", "30988534", "31033625", "31462806", "32915300", "31969443", "31704789", "30662115", "33358107", "31839083", "32179393", "31678959", "32308470", "33096517", "32092617"]}
{"metadata": {"review_pmid": "38334217"}, "inputs": {"background": "Morton's neuroma (MN) is a painful neuropathy resulting from a benign enlargement of the common plantar digital nerve that occurs commonly in the third webspace and, less often, in the second webspace of the foot. Symptoms include burning or shooting pain in the webspace that extends to the toes, or the sensation of walking on a pebble. These impact on weight-bearing activities and quality of life.", "objectives": "To assess the benefits and harms of interventions for MN.", "selection criteria": "We included all randomised, parallel-group trials (RCTs) of any intervention compared with placebo, control, or another intervention for MN. We included trials where allocation occurred at the level of the individual or the foot (clustered data). We included trials that confirmed MN through symptoms, a clinical test, and an ultrasound scan (USS) or magnetic resonance imaging (MRI)."}, "labels": ["23564425", "28617064", "33106028", "27037432", "35726101", "30062527", "27031544", "23636185"]}
{"metadata": {"review_pmid": "38334147"}, "inputs": {"background": "Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood. Methotrexate has broad immunomodulatory properties and is the most commonly used disease-modifying antirheumatic drug (DMARD). This is an update of a 2001 Cochrane review. It supports a living guideline for children and young people with JIA.", "objectives": "To assess the benefits and harms of methotrexate for children and young people with juvenile idiopathic arthritis.", "selection criteria": "We searched for RCTs that compared methotrexate with placebo, no treatment, or another DMARD (with or without concomitant therapies) in children and young people (aged up to 18 years) with JIA."}, "labels": ["1549149", "28162781", "15843668", "10943876"]}
{"metadata": {"review_pmid": "38323679"}, "inputs": {"background": "Cognitive behavioural therapy (CBT) can be effective in people with schizophrenia when provided in combination with antipsychotic medication. It remains unclear whether CBT could be safely and effectively offered in the absence of concomitant antipsychotic therapy.", "objectives": "To investigate the effects of CBT for schizophrenia when administered without concomitant pharmacological treatment with antipsychotics.", "selection criteria": "We included randomised controlled trials (RCTs) in people with schizophrenia comparing CBT without antipsychotics to standard care, standard care without antipsychotics, or the combination of CBT and antipsychotics."}, "labels": ["30024100", "30024100", "24508319", "30388270", "24508320", "30017459", "24516073", "29605186", "29605187", "29605187", "32775967", "32775968", "32649926", "36866165", "32649925", "33496261", "31272477"]}
{"metadata": {"review_pmid": "38323659"}, "inputs": {"background": "Giant cell arteritis (GCA) is a systemic, inflammatory vasculitis primarily affecting people over the age of 50 years. GCA is treated as a medical emergency due to the potential for sudden, irreversible visual loss. Temporal artery biopsy (TAB) is one of the five criteria of the American College of Rheumatology (ACR) 1990 classification, which is used to aid the diagnosis of GCA. TAB is an invasive test, and it can be slow to obtain a result due to delays in performing the procedure and the time taken for histopathologic assessment. Temporal artery ultrasonography (US) has been demonstrated to show findings in people with GCA such as the halo sign (a hypoechoic circumferential wall thickening due to oedema), stenosis or occlusion that can help to confirm a diagnosis more swiftly and less invasively, but requiring more subjective interpretation. This review will help to determine the role of these investigations in clinical practice.", "objectives": "To evaluate the sensitivity and specificity of the halo sign on temporal artery US, using the ACR 1990 classification as a reference standard, to investigate whether US could be used as triage for TAB. To compare the accuracy of US with TAB in the subset of paired studies that have obtained both tests on the same patients, to investigate whether it could replace TAB as one of the criteria in the ACR 1990 classification.", "selection criteria": "We included all participants with clinically suspected GCA who were investigated for the presence of the halo sign on temporal artery US, using the ACR 1990 criteria as a reference standard. We included studies with participants with a prior diagnosis of polymyalgia rheumatica. We excluded studies if participants had had two or more weeks of steroid treatment prior to the investigations. We also included any comparative test accuracy studies of the halo sign on temporal artery US versus TAB, with use of the 1990 ACR diagnostic criteria as a reference standard. Although we have chosen to use this classification for the purpose of the meta-analysis, we accept that it incorporates unavoidable incorporation bias, as TAB is itself one of the five criteria. This increases the specificity of TAB, making it difficult to compare with US. We excluded case-control studies, as they overestimate accuracy, as well as case series in which all participants had a prior diagnosis of GCA, as they can only address sensitivity and not specificity."}, "labels": ["29967570", "18668559", "24106211", "29871775", "18799059", "30318270", "20810501", "12064840", "14528514", "12186513", "9358127", "19809960", "27925577"]}
{"metadata": {"review_pmid": "38319008"}, "inputs": {"background": "Initial arch wires are the first arch wires inserted into fixed appliance at the beginning of orthodontic treatment. With a number of different types of orthodontic arch wires available for initial tooth alignment, it is important to understand which are most efficient and which cause the least amount of root resorption and pain during the initial aligning stage of treatment. This is the third update of a Cochrane review first published in 2010.", "objectives": "To assess the effects of initial arch wires for the alignment of teeth with fixed orthodontic braces, in terms of the rate of tooth alignment, amount of root resorption accompanying tooth movement, and intensity of pain experienced by patients during the initial alignment stage of treatment.", "selection criteria": "We included randomised controlled trials (RCTs) of different initial arch wires used to align teeth with fixed orthodontic braces. We included people with full-arch fixed orthodontic appliances on the upper arch, lower arch, or both arches."}, "labels": ["34614121", "31840204", "29732301", "34488744", "22259810", "9918641", "14994886", "9674677", "9857602", "34568209", "1456222", "2084149", "30923695", "35110162", "29478924", "26012120", "32011678", "29504810", "2086257", "21367826", "19651336", "29561654", "24351147", "24297959", "22011096", "30657251", "29173854", "7484965"]}
{"metadata": {"review_pmid": "38318932"}, "inputs": {"background": "The prevalence of gallstones varies between less than 1% and 64% in different populations and is thought to be increasing in response to changes in nutritional intake and increasing obesity. Some people with gallstones have no symptoms but approximately 2% to 4% develop them each year, predominantly including severe abdominal pain. People who experience symptoms have a greater risk of developing complications. The main treatment for symptomatic gallstones is cholecystectomy. Traditionally, a low-fat diet has also been advised to manage gallstone symptoms, but there is uncertainty over the evidence to support this.", "objectives": "To evaluate the benefits and harms of modified dietary fat intake in the treatment of gallstone disease in people of any age.", "selection criteria": "We included randomised clinical trials (irrespective of language, blinding, or status) in people with gallstones diagnosed using ultrasonography or conclusive imaging methods. We excluded participants diagnosed with another condition that may compromise dietary fat tolerance. We excluded trials where data from participants with gallstones were not reported separately from data from participants who did not have gallstones. We included trials that investigated other interventions (e.g. trials of drugs or other dietary (non-fat) components) providing that the trial groups had received the same proportion of drug or other dietary (non-fat) components in the intervention."}, "labels": ["27154810", "4036847", "3004189", "3014318", "709092", "7076005"]}
{"metadata": {"review_pmid": "38318883"}, "inputs": {"background": "Growth hormone (GH)-secreting pituitary adenoma is a severe endocrine disease. Surgery is the currently recommended primary therapy for patients with GH-secreting tumours. However, non-surgical therapy (pharmacological therapy and radiation therapy) may be performed as primary therapy or may improve surgical outcomes.", "objectives": "To assess the effects of surgical and non-surgical interventions for primary and salvage treatment of GH-secreting pituitary adenomas in adults.", "selection criteria": "Randomised controlled trials (RCTs) and quasi-RCTs of more than 12 weeks' duration, reporting on surgical, pharmacological, radiation, and combination interventions for GH-secreting pituitary adenomas in any healthcare setting."}, "labels": ["11607883", "19178516", "28825168", "18492760", "24866574", "26179177", "21575026", "22613412", "20061334", "21099129"]}
{"metadata": {"review_pmid": "38314898"}, "inputs": {"background": "Meibomian gland dysfunction (MGD) is the most common underlying cause of dry eye disease (DED). MGD leads to pathological alteration of the composition or quantity of meibum, or both, which subsequently results in tear evaporation and the typical signs and symptoms associated with DED. The LipiFlow Thermal Pulsation System (LipiFlow) is a medical device used to treat MGD in office; however, it is unclear if LipiFlow can outperform other DED treatments.", "objectives": "To evaluate the effectiveness of LipiFlow for treating DED signs and symptoms and the safety of LipiFlow compared with sham or other available treatments for MGD in adults.", "selection criteria": "We included studies conducted in adults (over 18 years of age) with DED or MGD as defined by the primary trial investigators. We imposed no restrictions on race, ethnicity, or sex. We considered trials involving contact lens wearers if they were equally represented between groups."}, "labels": ["24656693", "34581297", "29398903", "36065356", "33061275", "34822140", "36729441", "36112256", "32103887", "31895884", "35383732"]}
{"metadata": {"review_pmid": "38314855"}, "inputs": {"background": "The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to challenge the health workforce and societies worldwide. Favipiravir was suggested by some experts to be effective and safe to use in COVID-19. Although this drug has been evaluated in randomized controlled trials (RCTs), it is still unclear if it has a definite role in the treatment of COVID-19.", "objectives": "To assess the effects of favipiravir compared to no treatment, supportive treatment, or other experimental antiviral treatment in people with acute COVID-19.", "selection criteria": "We searched for RCTs evaluating the efficacy of favipiravir in treating people with COVID-19."}, "labels": ["35322077", "35026375", "35026375", "34539392", "34849615", "34888401", "36065065", "35446944", "32770240", "33115675", "36260627", "38225598", "36284645", "34956474", "36528039", "34453234", "35997325", "33735712", "35194422", "33212256", "33378989"]}
{"metadata": {"review_pmid": "38299639"}, "inputs": {"background": "IgA nephropathy (IgAN) is the most common primary glomerular disease, with approximately 20% to 40% of patients progressing to kidney failure within 25 years. Non-immunosuppressive treatment has become a mainstay in the management of IgAN by improving blood pressure (BP) management, decreasing proteinuria, and avoiding the risks of long-term immunosuppressive management. Due to the slowly progressive nature of the disease, clinical trials are often underpowered, and conflicting information about management with non-immunosuppressive treatment is common. This is an update of a Cochrane review, first published in 2011.", "objectives": "To assess the benefits and harms of non-immunosuppressive treatment for treating IgAN in adults and children. We aimed to examine all non-immunosuppressive therapies (e.g. anticoagulants, antihypertensives, dietary restriction and supplementation, tonsillectomy, and herbal medicines) in the management of IgAN.", "selection criteria": "Randomised controlled trials (RCTs) and quasi-RCTs of non-immunosuppressive agents in adults and children with biopsy-proven IgAN were included."}, "labels": ["2752395", "15462115", "21623600", "7758341", "2539929", "11938804", "10801253", "1857478", "29794482", "3555016", "12920628", "15031340", "17205814", "17342992", "25358874", "6994960", "6994960", "18685141", "18685141", "7935657", "10446945", "12105241", "8004831", "7935657", "10446945", "11274240", "17699310", "17699310", "12105241", "11274240", "8700366", "16159570", "21038654", "16632013", "16632013", "15894837", "17014562", "17497466", "8255008", "11783600", "17513327", "17513327", "14586719", "15055252", "15055252", "26874511", "15728401", "12940609", "12940609", "16932894", "24759301", "24759301", "2661066", "16841664", "18334143", "24280442", "23331443", "22019331", "22019331", "27347034", "30922594", "8052432", "8052432", "17699343", "17699247", "7485134", "11092994", "17954367", "12748343", "12748343", "9848785", "9848785", "10070170", "8026109", "12761258", "10862636", "11431176", "2105638", "12137603", "22116196", "29987456", "30284023", "18971549", "14640237", "23675422", "23596814", "11115082", "19473629", "19092821", "14989068", "27503012", "31768803", "26727697", "24191893", "9283216", "21977811"]}
{"metadata": {"review_pmid": "38288876"}, "inputs": {"background": "Laparoscopic surgery is the preferred option for many procedures. To properly perform laparoscopic surgery, it is essential that sudden movements and abdominal contractions in patients are prevented, as it limits the surgeon's view. There has been a growing interest in the potential beneficial effect of deep neuromuscular blockade (NMB) in laparoscopic surgery. Deep NMB improves the surgical field by preventing abdominal contractions, and it is thought to decrease postoperative pain. However, it is uncertain if deep NMB improves intraoperative safety and thereby improves clinical outcomes.", "objectives": "To evaluate the benefits and harms of deep neuromuscular blockade versus no, shallow, or moderate neuromuscular blockade during laparoscopic intra- or transperitoneal procedures in adults.", "selection criteria": "We included randomised clinical trials (irrespective of language, blinding, or publication status) in adults undergoing laparoscopic intra- or transperitoneal procedures comparing deep NMB to moderate, shallow, or no NMB. We excluded trials that did not report any of the primary or secondary outcomes of our review."}, "labels": ["35822730", "28107276", "28803124", "25125097", "32395901", "30920983", "29761274", "31503037", "37386582", "32506481", "30985536", "33651007", "33092803", "35186973", "35455677", "26945393", "30324626", "33479442", "34945780", "27405749", "29727028", "31455832", "34768608", "36181085", "32556699", "35014162", "28552090", "26479510", "24240315", "33877942", "34398011", "28643056", "35213496", "24809482", "27871505", "28251555", "24977638", "27936214", "31780139", "36357559", "26317357", "32748579"]}
{"metadata": {"review_pmid": "38284415"}, "inputs": {"background": "Patient decision aids are interventions designed to support people making health decisions. At a minimum, patient decision aids make the decision explicit, provide evidence-based information about the options and associated benefits/harms, and help clarify personal values for features of options. This is an update of a Cochrane review that was first published in 2003 and last updated in 2017.", "objectives": "To assess the effects of patient decision aids in adults considering treatment or screening decisions using an integrated knowledge translation approach.", "selection criteria": "We included published randomized controlled trials comparing patient decision aids to usual care. Usual care was defined as general information, risk assessment, clinical practice guideline summaries for health consumers, placebo intervention (e.g. information on another topic), or no intervention."}, "labels": ["20716619", "20484092", "29482225", "27203272", "26671675", "31521046", "21475138", "14678367", "11890241", "22809163", "26762150", "15271274", "15065100", "12900106", "30925280", "30618048", "29114896", "11281861", "22153756", "22608696", "23021156", "25344101", "33353864", "28754540", "27189020", "21807474", "22718559", "35436208", "26883201", "24048550", "25176023", "25301018", "25521472", "31225666", "30214066", "29201388", "34316804", "25010250", "23017384", "33741234", "33515972", "2970220", "30690645", "27803090", "35679576", "29752528", "30314830", "9190093", "21954198", "11958495", "33170506", "31829111", "32782181", "33538329", "31398258", "35209775", "20693148", "23395006", "21442198", "24004815", "32943031", "17696268", "22861171", "26195173", "18299490", "32955013", "31451360", "33170877", "28107540", "12790313", "15911190", "31268641", "27463536", "11562929", "17685733", "16968364", "23291316", "22091750", "23273855", "18766034", "22496116", "27919865", "30646167", "28001305", "23613362", "27893033", "27084853", "32564251", "20609546", "16478927", "28186933", "19049552", "12460093", "31822489", "33162270", "24913683", "28228452", "30195826", "31799940", "17389534", "35849397", "32897386", "23279388", "25247517", "32484533", "23835709", "20869187", "16024212", "26010755", "26414670", "18714075", "20629764", "22847969", "21483008", "22825933", "8998184", "20143439", "21319147", "21870192", "29847251", "32453274", "32891678", "35589905", "17509808", "26777101", "27070681", "32771369", "19959322", "21167033", "30608607", "10463708", "21764087", "20466791", "24908099", "23129571", "17954796", "20149953", "16129870", "12477613", "12084693", "20179125", "28590833", "30316931", "34409339", "26395873", "30408191", "27584910", "16377604", "25719814", "21565651", "32381556", "29532054", "31471729", "16004744", "12939889", "19385964", "20133502", "17540908", "21605732", "20003299", "31008776", "11089711", "24491609", "19786674", "32065499", "11532845", "11532844", "18190370", "16611368", "17217360", "33280968", "28859646", "28277290", "17319855", "16911143", "15242468", "29446209", "26343571", "28295915", "30630487", "30913217", "11085838", "31305282", "25146587", "17898242", "18039724", "27242081", "28505217", "34174455", "32546834", "20432110", "17689600", "32684500", "22753906", "30729166", "32310288", "34107740", "20484090", "23159252", "22496115", "11550168", "20876346", "19210013", "17005051", "22141447", "24575882", "16336366", "24148574", "25071062", "31067237", "27647529", "22871477", "22512746", "24421292", "20978060", "24564877", "26254238", "32173628", "28832310", "21636633", "32704380", "35483576", "30954312", "17119044", "33744300", "17214891", "17545350", "34890060", "18573775", "19590021", "35036345", "23188111", "20884700", "25940277", "22882966", "33457123", "30913472", "27075333", "19209172", "10418541", "15043176", "32003822", "15040791", "15544685", "34528271", "34452714", "16875796", "25322473", "19605885", "19250151", "17533211", "12697850", "15280341", "30031600", "23357414", "30773608", "8651843", "9597051", "10632830", "16709212", "33760077", "33191060", "34462283"]}
{"metadata": {"review_pmid": "38275741"}, "inputs": {"background": "Diabetic macular oedema (DMO) is a common complication of diabetic retinopathy. Antiangiogenic therapy with anti-vascular endothelial growth factor (anti-VEGF) can reduce oedema, improve vision, and prevent further visual loss. These drugs have replaced laser photocoagulation as the standard of care for people with DMO. In the previous update of this review, we found moderate-quality evidence that, at 12 months, aflibercept was slightly more effective than ranibizumab and bevacizumab for improving vision in people with DMO, although the difference may have been clinically insignificant (less than 0.1 logarithm of the minimum angle of resolution (logMAR), or five Early Treatment Diabetic Retinopathy Study (ETDRS) letters, or one ETDRS line).", "objectives": "The objective of this updated review was to compare the effectiveness and safety of the different anti-VEGF drugs in RCTs at longer followup (24 months).", "selection criteria": "We included randomised controlled trials (RCTs) that compared any anti-angiogenic drug with an anti-VEGF mechanism of action versus another anti-VEGF drug, another treatment, sham, or no treatment in people with DMO."}, "labels": ["31037289", "20416952", "22491395", "24013651", "32722955", "22537617", "21546089", "23974915", "22965591", "23807371", "22503301", "20427088", "21459214", "22999634", "25692915", "26935357", "35038415", "30645696", "34001667", "24531025", "23795985", "23544200", "19700194", "20855114", "20980427", "22999634", "23725735", "22399690", "21459215", "23974915", "24491642", "26453639", "25983216", "25148789", "23706949", "22965590", "22330964", "22234244", "18046223", "19376585", "26198808", "25012934", "35085503"]}
{"metadata": {"review_pmid": "38275196"}, "inputs": {"background": "Observational studies in preterm newborns suggest that delay in administering amino acids (AA) could result in a protein catabolic state and impact on growth and development.", "objectives": "The objective of this review was to compare the efficacy and safety of early versus late administration of intravenous AA in neonates born at < 37 weeks of gestation.", "selection criteria": "We included randomised controlled trials (RCTs) comparing early administration of AA with late administration in premature newborn infants. We defined early administration of AA solution as the administration of AA in isolation or with total parenteral nutrition within the first 24 hours of birth, and late administration as the administration of AA in isolation or with total parenteral nutrition after the first 24 hours of birth."}, "labels": ["18589451", "20830534", "7552604", "8433884", "2511809", "19573436", "16227030", "16627891", "25187104"]}
{"metadata": {"review_pmid": "38270182"}, "inputs": {"background": "Laryngeal mask airway surfactant administration (S-LMA) has the potential benefit of surfactant administration whilst avoiding endotracheal intubation and ventilation, ventilator-induced lung injury and bronchopulmonary dysplasia (BPD).", "objectives": "To evaluate the benefits and harms of S-LMA either as prophylaxis or treatment (rescue) compared to placebo, no treatment, or intratracheal surfactant administration via an endotracheal tube (ETT) with the intent to rapidly extubate (InSurE) or extubate at standard criteria (S-ETT) or via other less-invasive surfactant administration (LISA) methods on morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome (RDS).", "selection criteria": "Randomised controlled trials (RCTs), cluster- or quasi-RCTs of S-LMA compared to placebo, no treatment, or other routes of administration (nebulised, pharyngeal instillation of surfactant before the first breath, thin endotracheal catheter surfactant administration or intratracheal surfactant instillation) on morbidity and mortality in preterm infants at risk of RDS. We considered published, unpublished and ongoing trials."}, "labels": ["22893557", "28130967", "36241051", "36241051", "26633145", "30305714", "29174079", "29174079", "37919512", "27866188", "25221763"]}
{"metadata": {"review_pmid": "38269441"}, "inputs": {"background": "This is an updated version of a Cochrane Review first published in 2014. Phimosis is a condition in which the prepuce (foreskin) cannot be fully retracted past the head of the penis (glans). Phimosis is often treated surgically by circumcision or prepuce plasty; however, reports of non-invasive treatment using topical corticosteroids applied for four to eight weeks have suggested favorable outcomes.", "objectives": "To assess the effects of topical corticosteroids applied to the stenotic portion of the prepuce for the treatment of phimosis in boys compared with placebo or no treatment.", "selection criteria": "We included all randomized controlled trials (RCTs) that compared the use of any topical corticosteroid with placebo or no treatment for boys with any type or degree of phimosis."}, "labels": ["18157674", "8976781", "11125410", "16791612", "19692044", "9001879", "15764277", "11095086", "21756378", "17923208", "14633068"]}
{"metadata": {"review_pmid": "38264795"}, "inputs": {"background": "Balancing the risk of bleeding and thrombosis after acute myocardial infarction (AMI) is challenging, and the optimal antithrombotic therapy remains uncertain. The potential of non-vitamin K antagonist oral anticoagulants (NOACs) to prevent ischaemic cardiovascular events is promising, but the evidence remains limited.", "objectives": "To evaluate the efficacy and safety of non-vitamin-K-antagonist oral anticoagulants (NOACs) in addition to background antiplatelet therapy, compared with placebo, antiplatelet therapy, or both, after acute myocardial infarction (AMI) in people without an indication for anticoagulation (i.e. atrial fibrillation or venous thromboembolism).", "selection criteria": "We searched for randomised controlled trials (RCTs) that evaluated NOACs plus antiplatelet therapy versus placebo, antiplatelet therapy, or both, in people without an indication for anticoagulation after an AMI."}, "labels": ["19470889", "21780946", "25819860", "28438739", "26271059", "26109589", "31310855", "29447769", "29447769", "30217378", "30217378", "23860881", "19539361", "31898965", "25318481", "23602776", "29976285", "21570509", "21570509", "21570509", "30340765", "29249166", "23747777", "23500262", "23500262", "22077192", "23711804", "22586021", "31364490", "28325638", "26995378", "21551462"]}
{"metadata": {"review_pmid": "38258877"}, "inputs": {"background": "The intestinal microflora has an essential role in providing a barrier against colonisation of pathogens, facilitating important metabolic functions, stimulating the development of the immune system, and maintaining intestinal motility. Probiotics are live microorganisms that can be administered to supplement the gut flora. Neonates who have undergone gastrointestinal surgery are particularly susceptible to infectious complications in the postoperative period. This may be partly due to a disruption of the integrity of the gut and its intestinal microflora. There may be a role for probiotics in reducing the incidence of sepsis and improving intestinal motility, thus reducing morbidity and mortality and improving enteral feeding in neonates in the postoperative period.", "objectives": "To evaluate the efficacy and safety of administering probiotics after gastrointestinal surgery for the postoperative management of neonates born from 35 weeks of gestation.", "selection criteria": "We included randomised controlled trials (RCTs) that investigated the postoperative administration of oral probiotics versus placebo or no treatment in neonates born from 35 weeks of gestation who had one or more gastrointestinal surgical procedures. We applied no restrictions regarding the type or dosage of probiotics or the duration of treatment."}, "labels": ["34980887"]}
{"metadata": {"review_pmid": "38235907"}, "inputs": {"background": "Hepatorenal syndrome is a condition that occurs in people with chronic liver disease (such as alcoholic hepatitis, advanced cirrhosis, or fulminant liver failure) and portal hypertension. The prognosis is dismal, often with a survival of weeks to months. Hepatorenal syndrome is characterised by the development of intense splanchnic vasodilation favouring ascites and hypotension leading to renal vasoconstriction and acute renal failure. Therefore, treatment attempts focus on improving arterial pressure through the use of vasopressors, paracentesis, and increasing renal perfusion pressure. Several authors have reported that the placement of transjugular intrahepatic portosystemic shunts (TIPS) may be a therapeutic option because it decreases portal pressure and improves arterial and renal pressures. However, the evidence is not clearly documented and TIPS may cause adverse events. Accordingly, it is necessary to evaluate the evidence of the benefits and harms of TIPS to assess its value in people with hepatorenal syndrome.", "objectives": "To evaluate the benefits and harms of transjugular intrahepatic portosystemic shunts (TIPS) in adults with hepatorenal syndrome compared with sham, no intervention, conventional treatment, or other treatments.", "selection criteria": "We included only randomised clinical trials with a parallel-group design, which compared the TIPS placement with sham, no intervention, conventional therapy, or other therapies, in adults aged 18 years or older, regardless of sex or ethnicity, diagnosed with chronic liver disease and hepatorenal syndrome. We excluded trials of adults with kidney failure due to causes not related to hepatorenal syndrome, and we also excluded data from quasi-randomised, cross-over, and observational study designs as we did not design a separate search for such studies."}, "labels": ["12454841", "10841872"]}
{"metadata": {"review_pmid": "38235838"}, "inputs": {"background": "Pain, when treated inadequately, puts preterm infants at a greater risk of developing clinical and behavioural sequelae because of their immature pain system. Preterm infants in need of intensive care are repeatedly and persistently exposed to noxious stimuli, and this happens during a critical window of their brain development with peak rates of brain growth, exuberant synaptogenesis and the developmental regulation of specific receptor populations. Nearly two-thirds of infants born at less than 29 weeks' gestation require mechanical ventilation for some duration during the newborn period. These neonates are endotracheally intubated and require repeated endotracheal suctioning. Endotracheal suctioning is identified as one of the most frequent and most painful procedures in premature infants, causing moderate to severe pain. Even with improved nursing performance and standard procedures based on neonatal needs, endotracheal suctioning remains associated with mild pain.", "objectives": "To evaluate the benefits and harms of non-pharmacological interventions for the prevention of pain during endotracheal suctioning in mechanically ventilated neonates. Non-pharmacological interventions were compared to no intervention, standard care or another non-pharmacological intervention.", "selection criteria": "We included randomised controlled trials (RCTs), quasi-RCTs and cluster-RCTs that included term and preterm neonates who were mechanically ventilated via endotracheal tube or via tracheostomy tube and required endotracheal suctioning performed by doctors, nurses, physiotherapists or other healthcare professionals."}, "labels": ["24999148", "24266524", "16410042", "23316894", "29123341", "32316790", "35603088", "32690406", "15123970"]}
{"metadata": {"review_pmid": "38226724"}, "inputs": {"background": "Hip and knee replacement surgery is a well-established means of improving quality of life, but is associated with a significant risk of bleeding. One-third of people are estimated to be anaemic before hip or knee replacement surgery; coupled with the blood lost during surgery, up to 90% of individuals are anaemic postoperatively. As a result, people undergoing orthopaedic surgery receive 3.9% of all packed red blood cell transfusions in the UK. Bleeding and the need for allogeneic blood transfusions has been shown to increase the risk of surgical site infection and mortality, and is associated with an increased duration of hospital stay and costs associated with surgery. Reducing blood loss during surgery may reduce the risk of allogeneic blood transfusion, reduce costs and improve outcomes following surgery. Several pharmacological interventions are available and currently employed as part of routine clinical care.", "objectives": "To determine the relative efficacy of pharmacological interventions for preventing blood loss in elective primary or revision hip or knee replacement, and to identify optimal administration of interventions regarding timing, dose and route, using network meta-analysis (NMA) methodology.", "selection criteria": "We included RCTs of people undergoing elective hip or knee surgery only. We excluded non-elective or emergency procedures, and studies published since 2010 that had not been prospectively registered (Cochrane Injuries policy). There were no restrictions on gender, ethnicity or age (adults only). We excluded studies that used standard of care as the comparator. Eligible interventions included: antifibrinolytics (tranexamic acid (TXA), aprotinin, epsilon-aminocaproic acid (EACA)), desmopressin, factor VIIa and XIII, fibrinogen, fibrin sealants and non-fibrin sealants."}, "labels": ["18067499", "30902396", "30902396", "8636182", "10919295", "11728069", "28976426", "31474134", "31474134", "16531440", "29637282", "34705756", "32095290", "17966532", "30700116", "17767075", "31407549", "10098585", "11049894", "11704449", "11606830", "11226117", "1529684", "1796409", "15188109", "23906869", "25471907", "34255299", "12697586", "27567057", "27567057", "12067170", "12067170", "8832445", "7772427", "9085968", "14763696", "10673876", "7507304", "12678347", "16156456", "31800425", "20640094", "20640094", "33962594", "32819929", "33295133", "7929503", "7929503", "27113948", "28244907", "31473130", "11112196", "28567578", "29759857", "32253548", "14709457", "24997651", "26991616", "28368940", "34601160", "17356139", "33443925", "7529467", "10819278", "16470437", "26703193", "16487712", "29966112", "34479593", "16429938", "15978098", "15978098", "7572006", "31256650", "33148955", "28662956", "11476309", "31638960", "32053522", "9028087", "12421192", "15887746", "32152813", "30062946", "31653221", "30845038", "30597504", "30312799", "30312799", "27262419", "29092982", "34794198", "34668331", "34668331", "15224162", "33094562", "27663190", "29410968", "33511201", "28093896", "28093896", "29396806", "18277670", "29492612", "15562053"]}
{"metadata": {"review_pmid": "38226663"}, "inputs": {"background": "Pilonidal sinus disease is a common and debilitating condition. Surgical treatment remains the mainstay for managing chronic disease, with options including midline and off-midline wound closure methods. However, the optimal approach remains uncertain. Recent developments in tension-free midline techniques require further exploration.", "objectives": "To assess the effects of midline and off-midline wound closure methods for pilonidal sinus, and to determine the optimal off-midline flap procedures.", "selection criteria": "We included parallel RCTs involving participants undergoing midline closure without flap techniques and off-midline closure for pilonidal sinus treatment. We excluded quasi-experimental studies and studies that enroled participants presenting with an abscess."}, "labels": ["10391165", "16078300", "31113167", "30286636", "23430349", "26039952", "23478617", "20122682", "23904719", "25363174", "16105524", "23732258", "35289848", "31354153", "24426425", "32459755", "20637332", "22057753", "25492279", "26138521", "26531235", "25831644", "21354343"]}
{"metadata": {"review_pmid": "38224135"}, "inputs": {"background": "Clinical practice guidelines recommend testosterone replacement therapy (TRT) for men with sexual dysfunction and testosterone deficiency. However, TRT is commonly promoted in men without testosterone deficiency and existing trials often do not clearly report participants' testosterone levels or testosterone-related symptoms. This review assesses the potential benefits and harms of TRT in men presenting with complaints of sexual dysfunction.", "objectives": "To assess the effects of testosterone replacement therapy compared to placebo or other medical treatments in men with sexual dysfunction.", "selection criteria": "We included randomized controlled trials (RCTs) in men (40 years or over) with sexual dysfunction. We excluded men with primary or secondary hypogonadism. We compared testosterone or testosterone with phosphodiesterase-5 inhibitors (PDEI5I) to placebo or PDE5I alone."}, "labels": ["20967981", "18528400", "20220293", "20646185", "8800895", "22834649", "518286", "12809074", "26498057", "26498057", "26498057", "27329542", "20704642", "6380630", "19118875", "17538639", "20524974", "20524974", "20524974", "20524974", "32844712", "29708829", "24355040", "24355040", "23551886", "28771964", "27124889", "28771964", "32384175", "15596419", "22093057", "23651425", "22635164", "11932266", "23581697", "19211706", "26030346", "23926681", "34871580", "37326322", "37589949", "7395237", "27436077", "27436077", "16390499", "19883295", "26158605", "10096389", "9146812", "15477371", "12788872", "23347341", "23347341", "15247755", "18405769", "26554661", "28241355", "27355400", "26886521", "24686158", "23494931", "23165659", "29463970"]}
{"metadata": {"review_pmid": "38205864"}, "inputs": {"background": "Rates of asthma are high in children and adolescents, and young people with asthma generally report poorer health outcomes than those without asthma. Young people with asthma experience a range of challenges that may contribute to psychological distress. This is compounded by the social, psychological, and developmental challenges experienced by all people during this life stage. Psychological interventions (such as behavioural therapies or cognitive therapies) have the potential to reduce psychological distress and thus improve behavioural outcomes such as self-efficacy and medication adherence. In turn, this may reduce medical contacts and asthma attacks.", "objectives": "To determine the efficacy of psychological interventions for modifying health and behavioural outcomes in children with asthma, compared with usual treatment, treatment with no psychological component, or no treatment.", "selection criteria": "We included randomised controlled trials (RCTs) comparing psychological interventions of any duration with usual care, active controls, or a waiting-list control in male and female children and adolescents (aged five to 18 years) with asthma."}, "labels": ["5076496", "33932626", "20462632", "20462632", "18411832", "33004234", "19246041", "8153036", "1968453", "2874221", "33307900", "329902", "351664", "373642", "30657230", "24588407", "25186121", "30185428", "24588407", "20858029", "32875137", "16014820"]}
{"metadata": {"review_pmid": "38205823"}, "inputs": {"background": "Diabetic peripheral neuropathy (DPN) is a frequent complication in people living with type 1 or type 2 diabetes. There is currently no effective treatment for DPN. Although alpha-lipoic acid (ALA, also known as thioctic acid) is widely used, there is no consensus about its benefits and harms.", "objectives": "To assess the effects of alpha-lipoic acid as a disease-modifying agent in people with diabetic peripheral neuropathy.", "selection criteria": "We included randomised clinical trials (RCTs) that compared ALA with placebo in adults (aged 18 years or older) and that applied the study interventions for at least six months. There were no language restrictions."}, "labels": ["10499773", "10480774", "21775755"]}
{"metadata": {"review_pmid": "38197546"}, "inputs": {"background": "Cholera causes acute watery diarrhoea and death if not properly treated. Outbreaks occur in areas with poor sanitation, including refugee camps. Several vaccines have been developed and tested over the last 50 years. This is an update of a Cochrane review, originally published in 1998, which explored the effects of all vaccines for preventing cholera. This review examines oral vaccines made from killed bacteria.", "objectives": "To assess the effectiveness and safety of the available World Health Organization (WHO)-prequalified oral killed cholera vaccines among children and adults.", "selection criteria": "We included randomized controlled trials (RCTs), including cluster-RCTs. There were no restrictions on the age and sex of the participants or the setting of the study. We considered any available WHO-prequalified oral killed cholera vaccine as an intervention. The control group was given a placebo, another vaccine, or no vaccine. The outcomes were related to vaccine effectiveness and safety. We included articles published in English only."}, "labels": ["24140390", "29463233", "22028938", "19819004", "34146473", "28196715", "26164097", "31092224", "29550406", "27144848", "7967990", "10823767"]}
{"metadata": {"review_pmid": "38197528"}, "inputs": {"background": "Over 1.3 million people die each year as a result of traffic collisions and hundreds of thousands of others are permanently and seriously injured. Most of these deaths occur in low- and middle-income countries, where mortality rates can be up to 10 times higher than those of some high-income countries. Seat belts are designed to accomplish two key functions - to prevent the occupant from being ejected from the vehicle by the force of impact, and to extend the time that the decelerating force is applied to a person. Seat belts also spread the area of impact both to larger and less vulnerable parts of the body. Since the 1950s, seat belts have been factory-fitted to most vehicles, and today around 90% of high-income countries have adopted seat belt legislation that makes it mandatory for some, if not all, vehicle occupants to wear seat belts. However, the simple passing of laws is not sufficient to ensure seat belt use, and, while the enforcement of seat belt laws does increase seat belt use, other interventions have been developed to encourage voluntary - and hence sustainable - behaviour change.", "objectives": "To evaluate the benefits of behavioural-change interventions (educational-based, incentive-based, engineering-based, or a combination, but not enforcement-based) that promote the use of seat belts, and to determine which types of interventions are most effective.", "selection criteria": "We included randomised controlled trials (RCTs), both individually randomised and cluster-randomised, that evaluated education, engineering, incentive-based interventions (or combinations) that promoted seat belt use."}, "labels": ["32947176", "20226949", "18439196", "19814758", "10150537", "1414449", "12165577", "22633251", "10160231", "23802878", "25412712", "11875146", "36129713"]}
{"metadata": {"review_pmid": "38197473"}, "inputs": {"background": "Emotional and behavioural difficulties (EBD) in children are common, characterised by externalising or internalising behaviours that can be highly stable over time. EBD are an important cause of functional disability in childhood, and predictive of poorer psychosocial, academic, and occupational functioning into adolescence and adulthood. The prevalence, stability, and long-term consequences of EBD highlight the importance of intervening in childhood when behavioural patterns are more easily modified. Multiple factors contribute to the aetiology of EBD in children, and parenting plays an important role. The relationship between parenting and EBD has been described as bidirectional, with parents and children shaping one another's behaviour. One consequence of bidirectionality is that parents with insufficient parenting skills may become involved in increasingly negative behaviours when dealing with non-compliance in children. This can have a cyclical effect, exacerbating child behavioural difficulties and further increasing parental distress. Behavioural or skills-based parenting training can be highly effective in addressing EBD in children. However, emotional dysregulation may intercept some parents' ability to implement parenting skills, and there is recognition that skills-based interventions may benefit from adjunct components that better target parental emotional responses. Mindful parenting interventions have demonstrated some efficacy in improving child outcomes via improvements in parental emotion regulation, and there is potential for mindfulness training to enhance the effectiveness of standard parent training programmes.", "objectives": "To assess the effectiveness of mindfulness-enhanced parent training programmes on the psychosocial functioning of children (aged 0 to 18 years) and their parents.", "selection criteria": "We included randomised and quasi-randomised trials. Participants were parents or caregivers of children under the age of 18. The intervention was mindfulness-enhanced parent training programmes compared with a no-intervention, waitlist, or attentional control, or a parent training programme with no mindfulness component. The intervention must have combined mindfulness parent training with behavioural or skills-based parent training. We defined parent training programmes in terms of the delivery of a standardised and manualised intervention over a specified and limited period, on a one-to-one or group-basis, with a well-defined mindfulness component. The mindfulness component must have included mindfulness training (breath, visualisation, listening, or other sensory focus) and an explicit focus on present-focused attention and non-judgemental acceptance."}, "labels": ["30447510", "24013587", "19680815", "25365122", "28386808", "31588254", "17481461", "28913717", "31068878", "32532175", "35040001", "32238534", "27798022", "24709926"]}
{"metadata": {"review_pmid": "38189593"}, "inputs": {"background": "Haemodialysis (HD) requires safe and effective anticoagulation to prevent clot formation within the extracorporeal circuit during dialysis treatments to enable adequate dialysis and minimise adverse events, including major bleeding. Low molecular weight heparin (LMWH) may provide a more predictable dose, reliable anticoagulant effects and be simpler to administer than unfractionated heparin (UFH) for HD anticoagulation, but may accumulate in the kidneys and lead to bleeding.", "objectives": "To assess the efficacy and safety of anticoagulation strategies (including both heparin and non-heparin drugs) for long-term HD in people with kidney failure. Any intervention preventing clotting within the extracorporeal circuit without establishing anticoagulation within the patient, such as regional citrate, citrate enriched dialysate, heparin-coated dialysers, pre-dilution haemodiafiltration (HDF), and saline flushes were also included.", "selection criteria": "Randomised controlled trials (RCTs) and quasi-randomised controlled studies (quasi-RCTs) evaluating anticoagulant agents administered during HD treatment in adults and children with kidney failure."}, "labels": ["30686542", "36210622", "15034156", "17660653", "2558829", "11684550", "9394322", "2943643", "9249774", "10867543", "18181808", "1819317", "24459138", "20615906", "22013932", "20659908", "28407129", "28407129", "35155859", "10940744", "9681723", "9681723", "26076014", "23354187", "9096446", "17472846", "17472846", "33940113", "25362223", "25362223", "3548336", "8678062", "32518865", "2459635", "15593057", "16144857", "17347579", "24825343", "7753456", "2417351", "25007166", "23725299", "9684701", "8648924", "23104956", "18305385", "26609786", "26609786", "11007833", "29351783", "31856749", "31856749", "12377628", "11919404", "34086880", "33663073", "21129229", "21129229", "31162876", "9284597", "8944937", "15569338", "14633147", "12808176", "17895513", "17389624", "23959669", "17920287", "17920287", "18234290", "1661121", "8462205", "34279471", "12407644", "17162433", "11493282", "20626736", "24261328", "1745997", "20682597", "19925286", "19758969", "34345413", "21659742", "10534515", "10534515", "23013946", "20530518", "11169003", "12372942", "23280073", "548596", "27325599", "26303208", "36379612", "33564444", "10584996", "2347652", "25623561", "35006070", "3107378", "27478610", "28052451", "20356555"]}
{"metadata": {"review_pmid": "38189560"}, "inputs": {"background": "Electronic cigarettes (ECs) are handheld electronic vaping devices which produce an aerosol by heating an e-liquid. People who smoke, healthcare providers and regulators want to know if ECs can help people quit smoking, and if they are safe to use for this purpose. This is a review update conducted as part of a living systematic review.", "objectives": "To examine the safety, tolerability and effectiveness of using electronic cigarettes (ECs) to help people who smoke tobacco achieve long-term smoking abstinence, in comparison to non-nicotine EC, other smoking cessation treatments and no treatment.", "selection criteria": "We included trials in which people who smoke were randomized to an EC or control condition. We also included uncontrolled intervention studies in which all participants received an EC intervention as these studies have the potential to provide further information on harms and longer-term use. Studies had to report an eligible outcome."}, "labels": ["25358095", "29304395", "34859526", "31779689", "31779689", "24485579", "24029165", "23496861", "25814920", "27322745", "23826093", "27543458", "26749533", "26729619", "23358230", "33723598", "37014673", "31956726", "29127080", "30500925", "33857436", "34850164", "26941050", "30393015", "30365024", "35752091", "35752091", "35752091", "32389072", "30203076", "33095798", "35134961", "28718828", "35869375", "33170240", "32462131", "33988520", "36727168", "35380498", "39827790", "30006020", "31740017", "27613896", "32770246", "30071863", "30699054", "31434605", "31597207", "33430407", "36344702", "35577966", "29791259", "30290121", "31828315", "29986786", "31171977", "29335291", "32343994", "36450821", "33756301", "34128486", "28376818", "35971150", "34827200", "27097389", "30280019", "31300577", "31300577", "31838445", "36421329", "36421329", "26842790", "30239904", "29660034", "35614523", "34175001", "28648969", "35491736", "31578724", "26333731", "27613880", "26444980", "34929031", "34435305", "34187081", "24629555", "34669956", "25762758", "31470240", "26184244", "21989407", "23873169", "25380748", "25811767", "27043170", "35363874", "35820869", "28003511", "33837422", "33837422", "34105208", "34105208", "36857841", "35351805", "33206193", "35022796", "35022796", "34284312", "34284312", "33046080", "34536632", "35405479", "31403695", "26712843", "27942543", "35738868", "35742698", "26783292", "29083287", "24148175", "35575085", "27932811", "27769828", "29248487", "31515173", "30808668", "35995103", "31698920"]}
{"metadata": {"review_pmid": "38189494"}, "inputs": {"background": "Burn damage to skin often results in scarring; however in some individuals the failure of normal wound-healing processes results in excessive scar tissue formation, termed 'hypertrophic scarring'. The most commonly used method for the prevention and treatment of hypertrophic scarring is pressure-garment therapy (PGT). PGT is considered standard care globally; however, there is continued uncertainty around its effectiveness.", "objectives": "To evaluate the benefits and harms of pressure-garment therapy for the prevention of hypertrophic scarring after burn injury.", "selection criteria": "We included randomised controlled trials (RCTs) comparing PGT (alone or in combination with other scar-management therapies) with scar management therapies not including PGT, or comparing different PGT pressures or different types of PGT."}, "labels": ["20541324", "8537416", "20537469", "2205610", "21223649", "20375696", "29947328", "30601234", "15994014", "34107792", "31565952"]}
{"metadata": {"review_pmid": "38189492"}, "inputs": {"background": "Vitamin B", "objectives": "To evaluate the benefits and harms of oral vitamin B", "selection criteria": "Randomised controlled trials (RCTs), quasi-RCTs, or cluster-RCTs evaluating the effects of oral vitamin B"}, "labels": ["24598885", "31296936", "28402324", "32470975", "27356547", "30003521", "5641006", "14297280", "25648738", "32302504", "32302504"]}
{"metadata": {"review_pmid": "38189479"}, "inputs": {"background": "Carpal tunnel syndrome (CTS) is a compression neuropathy of the median nerve at the wrist. Surgery is considered when symptoms persist despite the use of non-surgical treatments. It is unclear whether surgery produces a better outcome than non-surgical therapy. This is an update of a Cochrane review published in 2008.", "objectives": "To assess the evidence regarding the benefits and harms of carpal tunnel release compared with non-surgical treatment in the short (< 3 months) and long (> 3 months) term.", "selection criteria": "We included randomised controlled trials comparing any surgical technique with any non-surgical therapies for CTS."}, "labels": ["26182774", "26281946", "32766779", "30501389", "28295825", "28158963", "14132628", "12215131", "11801195", "17109748", "15933495", "15985575", "19782873", "15656907", "24321619", "32757777", "22467087", "15692981", "16871409", "30915366", "30915366"]}
{"metadata": {"review_pmid": "38180268"}, "inputs": {"background": "Cocaine is a psychostimulant used by approximately 0.4% of the general population worldwide. Cocaine dependence is a chronic mental disorder characterised by the inability to control cocaine use and a host of severe medical and psychosocial complications. There is current no approved pharmacological treatment for cocaine dependence. Some researchers have proposed disulfiram, a medication approved to treat alcohol use disorder. This is an update of a Cochrane review first published in 2010.", "objectives": "To evaluate the efficacy and safety of disulfiram for the treatment of cocaine dependence.", "selection criteria": "We included randomised controlled trials that evaluated disulfiram alone or associated with psychosocial interventions versus placebo, no intervention, other pharmacological interventions, or any psychosocial intervention for the treatment of cocaine dependence."}, "labels": ["23567610", "9692270", "9692270", "14993114", "14993114", "22695473", "22695473", "26817621", "28714728", "26817621", "28714728", "10862808", "17174102", "17174102", "31087723", "22906516", "22925276", "23849431", "23635803", "23335901", "33953123", "23648640", "20828943", "20828943", "20828943", "10723850", "18079068", "18079068", "24462581"]}
{"metadata": {"review_pmid": "38180112"}, "inputs": {"background": "Around one-third of older adults aged 65 years or older who live in the community fall each year. Interventions to prevent falls can be designed to target the whole community, rather than selected individuals. These population-level interventions may be facilitated by different healthcare, social care, and community-level agencies. They aim to tackle the determinants that lead to risk of falling in older people, and include components such as community-wide polices for vitamin D supplementation for older adults, reducing fall hazards in the community or people's homes, or providing public health information or implementation of public health programmes that reduce fall risk (e.g. low-cost or free gym membership for older adults to encourage increased physical activity).", "objectives": "To review and synthesise the current evidence on the effects of population-based interventions for preventing falls and fall-related injuries in older people. We defined population-based interventions as community-wide initiatives to change the underlying societal, cultural, or environmental conditions increasing the risk of falling.", "selection criteria": "We included randomised controlled trials (RCTs), cluster RCTs, trials with stepped-wedge designs, and controlled non-randomised studies evaluating population-level interventions for preventing falls and fall-related injuries in adults \u2265 60 years of age. Population-based interventions target entire communities. We excluded studies only targeting people at high risk of falling or with specific comorbidities, or residents living in institutionalised settings."}, "labels": ["16824563", "9599862", "11493044", "15040824", "15977461", "11593439", "19819593", "11602125", "3616279", "3787213", "3393927", "17624008", "19651998", "8944864"]}
{"metadata": {"review_pmid": "38180091"}, "inputs": {"background": "Children often require pain management following surgery to avoid suffering. Effective pain management has consequences for healing time and quality of life. Ibuprofen, a frequently used non-steroidal anti-inflammatory drug (NSAID) administered to children, is used to treat pain and inflammation in the postoperative period.", "objectives": "1) To assess the efficacy and safety of ibuprofen (any dose) for acute postoperative pain management in children compared with placebo or other active comparators. 2) To compare ibuprofen administered at different doses, routes (e.g. oral, intravenous, etc.), or strategies (e.g. as needed versus as scheduled).", "selection criteria": "We included randomised controlled trials (RCTs) in children aged 17 years and younger, treated for acute postoperative or postprocedural pain, that compared ibuprofen to placebo or any active comparator. We included RCTs that compared different administration routes, doses of ibuprofen and schedules."}, "labels": ["36088270", "36088270", "36517336", "36517336", "31094614", "33986479", "36855440", "9308064", "11455373", "17920504", "18947538", "17920505", "36052360", "29018084", "29018084", "9432075", "30946442", "22284284", "35592817", "17397460", "27424011", "30289371", "21644837", "7941942", "24660156", "1551152", "24150660", "35223652", "24646068", "8017354", "34674670", "11881888", "16279825", "15825785", "7617493", "34121357", "35987678", "35987678", "19361739", "32268439", "11113797", "31651801", "31651801", "23882088", "35476115", "12925475"]}
{"metadata": {"review_pmid": "38174816"}, "inputs": {"background": "During a stimulated cycle of in vitro fertilisation or intracytoplasmic sperm injection (IVF/ICSI), women receive daily doses of gonadotropin follicle-stimulating hormone (FSH) to induce multifollicular development in the ovaries. A normal response to stimulation (e.g. retrieval of 5 to 15 oocytes) is considered desirable. Generally, the number of eggs retrieved is associated with the dose of FSH. Both hyper-response and poor response are associated with an increased chance of cycle cancellation. In hyper-response, this is due to increased risk of ovarian hyperstimulation syndrome (OHSS), while poor response cycles are cancelled because the quantity and quality of oocytes is expected to be low. Clinicians often individualise the FSH dose using patient characteristics predictive of ovarian response. Traditionally, this meant women's age, but increasingly, clinicians use various ovarian reserve tests (ORTs). These include basal FSH (bFSH), antral follicle count (AFC), and anti-M\u00fcllerian hormone (AMH). It is unclear whether individualising FSH dose improves clinical outcomes. This review updates the 2018 version.", "objectives": "To assess the effects of individualised gonadotropin dose selection using markers of ovarian reserve in women undergoing IVF/ICSI.", "selection criteria": "We included randomised controlled trials (RCTs) that compared (a) different doses of FSH in women with a defined ORT profile (i.e. predicted low, normal, or high responders based on AMH, AFC, and/or bFSH) or (b) an individualised dosing strategy (based on at least one ORT measure) versus uniform dosing or a different individualised dosing algorithm."}, "labels": ["28189417", "25256937", "27236602", "11163812", "12416651", "33272623", "33722477", "20353458", "15591079", "23953069", "26361207", "35595197", "28175316", "27912901", "25596910", "29121269", "14688163", "30895268", "14585873", "34179971", "15844733", "29121326", "12568839"]}
{"metadata": {"review_pmid": "38174814"}, "inputs": {"background": "Chronic lymphocytic leukaemia (CLL) is the most common lymphoproliferative disease in adults and currently remains incurable. As the progression-free period shortens after each successive treatment, strategies such as maintenance therapy are needed to improve the degree and duration of response to previous therapies. Monoclonal antibodies, immunomodulatory agents, and targeted therapies are among the available options for maintenance therapy. People with CLL who achieve remission after previous therapy may choose to undergo medical observation or maintenance therapy to deepen the response. Even though there is widespread use of therapeutic maintenance agents, the benefits and harms of these treatments are still uncertain.", "objectives": "To assess the effects and safety of maintenance therapy, including anti-CD20 monoclonal antibody, immunomodulatory drug therapy, anti-CD52 monoclonal antibody, Bruton tyrosine kinase inhibitor, and B-cell lymphoma-2 tyrosine kinase inhibitor, for individuals with CLL.", "selection criteria": "We included RCTs with prospective identification of participants. We excluded cluster-randomised trials, cross-over trial designs, and non-randomised studies. We included studies comparing maintenance therapies with placebo/observation or head-to-head comparisons."}, "labels": ["30030269", "28958469", "29275118", "28916311", "24415640", "30888118", "27374465", "26784000", "29427355", "19016732", "15071604", "31801940", "26377300", "26970533"]}
{"metadata": {"review_pmid": "38174786"}, "inputs": {"background": "Researchers and decision-makers often use evidence from randomised controlled trials (RCTs) to determine the efficacy or effectiveness of a treatment or intervention. Studies with observational designs are often used to measure the effectiveness of an intervention in 'real world' scenarios. Numerous study designs and their modifications (including both randomised and observational designs) are used for comparative effectiveness research in an attempt to give an unbiased estimate of whether one treatment is more effective or safer than another for a particular population. An up-to-date systematic analysis is needed to identify differences in effect estimates from RCTs and observational studies. This updated review summarises the results of methodological reviews that compared the effect estimates of observational studies with RCTs from evidence syntheses that addressed the same health research question.", "objectives": "To assess and compare synthesised effect estimates by study type, contrasting RCTs with observational studies. To explore factors that might explain differences in synthesised effect estimates from RCTs versus observational studies (e.g. heterogeneity, type of observational study design, type of intervention, and use of propensity score adjustment). To identify gaps in the existing research comparing effect estimates across different study types.", "selection criteria": "We included systematic methodological reviews that compared quantitative effect estimates measuring the efficacy or effectiveness of interventions tested in RCTs versus in observational studies. The included reviews compared RCTs to observational studies (including retrospective and prospective cohort, case-control and cross-sectional designs). Reviews were not eligible if they compared RCTs with studies that had used some form of concurrent allocation."}, "labels": ["27878807", "28176959", "24607083", "29735376", "10861324", "14576955", "35538478", "22711757", "9474068", "22449722", "18303468", "21559325", "31195162", "10729689", "34865623", "34865623", "33860138", "33724337", "11497536", "34225716", "33731727", "23842008", "26086943", "21482068", "27370013", "24096758", "11134917", "33359322", "35537738", "34388312", "20346627", "21687681", "35113227", "16505459", "33080342", "23510555", "34526355", "33134323", "22065657", "32249144", "30554539", "30544134", "34098926", "26321114"]}
{"metadata": {"review_pmid": "38174776"}, "inputs": {"background": "Different therapeutic strategies are available for the treatment of people with relapsing-remitting multiple sclerosis (RRMS), including immunomodulators, immunosuppressants and biological agents. Although each one of these therapies reduces relapse frequency and slows disability accumulation compared to no treatment, their relative benefit remains unclear. This is an update of a Cochrane review published in 2015.", "objectives": "To compare the efficacy and safety, through network meta-analysis, of interferon beta-1b, interferon beta-1a, glatiramer acetate, natalizumab, mitoxantrone, fingolimod, teriflunomide, dimethyl fumarate, alemtuzumab, pegylated interferon beta-1a, daclizumab, laquinimod, azathioprine, immunoglobulins, cladribine, cyclophosphamide, diroximel fumarate, fludarabine, interferon beta 1-a and beta 1-b, leflunomide, methotrexate, minocycline, mycophenolate mofetil, ofatumumab, ozanimod, ponesimod, rituximab, siponimod and steroids for the treatment of people with RRMS.", "selection criteria": "Randomised controlled trials (RCTs) that studied one or more of the available immunomodulators and immunosuppressants as monotherapy in comparison to placebo or to another active agent, in adults with RRMS."}, "labels": ["9484361", "24794721", "25265472", "28607743", "22521274", "25891549", "16510744", "22008873", "22417253", "24029546", "32757523", "32757523", "32852530", "27473139", "19279320", "22232347", "19729344", "27177997", "3302705", "24535134", "18946064", "27000249", "27885061", "23122652", "27885061", "23122650", "27733571", "28817997", "23263473", "28140753", "20089960", "29716436", "30883839", "33331183", "23424159", "34378456", "28751099", "22992072", "28328179", "23749293", "24150778", "25681448", "28485186", "28080250", "26444729", "27251051", "28104250", "29055471", "24989666", "25270680", "23797999", "28751099", "22992073", "28328179", "24150779", "16629762", "18074075", "9057729", "22494956", "20089952", "25876471", "22751847", "25662353", "28989795", "24685276", "28989795", "28210662", "23686821", "25542295", "26394270", "23915113", "24576156", "29063244", "1985289", "8469318", "11988242", "7617181", "8301153", "16510769", "12453070", "25402490", "9050955", "25907350", "24841321", "8602746", "28002679", "30844611", "30820738", "28002679", "30844611", "30820738", "33779698", "9820297", "30217172", "31492652", "18789766", "27645341", "24375015", "23562009", "24022270", "27063626", "26806217", "29055471", "31492651", "33454584", "22723573", "21991951", "23852658", "28828394", "23447359", "24461574", "29796289", "24972678", "30348586", "30511679", "24812043", "20089954", "23632946", "25876473", "25545026"]}
{"metadata": {"review_pmid": "38096386"}, "inputs": {"background": "Lumbar puncture is a common invasive procedure performed in newborns for diagnostic and therapeutic purposes. Approximately one in two lumbar punctures fail, resulting in both short- and long-term negative consequences for the clinical management of patients. The most common positions used to perform lumbar puncture are the lateral decubitus and sitting position, and each can impact the success rate and safety of the procedure. However, it is uncertain which position best improves patient outcomes.", "objectives": "To assess the benefits and harms of the lateral decubitus, sitting, and prone positions for lumbar puncture in newborn infants.", "selection criteria": "We included randomized controlled trials (RCTs) and quasi-RCTs involving newborn infants of postmenstrual age up to 46 weeks and 0 days, undergoing lumbar puncture for any indication, comparing different positions (i.e. lateral decubitus, sitting, and prone position) during the procedure."}, "labels": ["34980050", "26417957", "32295554", "36460015", "12437706", "6637909"]}
{"metadata": {"review_pmid": "38095590"}, "inputs": {"background": "Many people receiving palliative care have reduced oral intake during their illness, and particularly at the end of their life. Management of this can include the provision of medically assisted hydration (MAH) with the aim of improving their quality of life (QoL), prolonging their life, or both. This is an updated version of the original Cochrane Review published in Issue 2, 2008, and updated in February 2011 and March 2014.", "objectives": "To determine the effectiveness of MAH compared with placebo and standard care, in adults receiving palliative care on their QoL and survival, and to assess for potential adverse events.", "selection criteria": "We included all relevant randomised controlled trials (RCTs) of studies of MAH in adults receiving palliative care aged 18 and above. The criteria for inclusion was the comparison of MAH to placebo or standard care."}, "labels": ["15800328", "23169523", "12411847", "29343167"]}
{"metadata": {"review_pmid": "38088821"}, "inputs": {"background": "Otitis media with effusion (OME) is an accumulation of fluid in the middle ear cavity, common amongst young children. The fluid may cause hearing loss. Although most episodes of OME in children resolve spontaneously within a few months, when persistent it may lead to behavioural problems and a delay in expressive language skills. Management of OME includes watchful waiting, medical, surgical and other treatments, such as autoinflation. Oral or topical steroids are sometimes used to reduce inflammation in the middle ear.", "objectives": "To assess the effects (benefits and harms) of topical and oral steroids for OME in children.", "selection criteria": "We included randomised controlled trials (RCTs) and quasi-randomised trials in children aged 6 months to 12 years with unilateral or bilateral OME. We included studies that compared topical or oral steroids with either placebo or watchful waiting (no treatment)."}, "labels": ["22091267", "2235167", "25151658", "16169093", "16169093", "19434268", "9153098", "28807086", "12422079", "3108758", "3108758", "6752070", "4038553", "12456902", "30152390", "30407151", "26931619", "2248740", "3915207", "28894551", "6778331", "6778331", "20345546", "19671372", "20015903"]}
{"metadata": {"review_pmid": "38084817"}, "inputs": {"background": "Substance use is a global issue, with around 30 to 35 million individuals estimated to have a substance-use disorder. Motivational interviewing (MI) is a client-centred method that aims to strengthen a person's motivation and commitment to a specific goal by exploring their reasons for change and resolving ambivalence, in an atmosphere of acceptance and compassion. This review updates the 2011 version by Smedslund and colleagues.", "objectives": "To assess the effectiveness of motivational interviewing for substance use on the extent of substance use, readiness to change, and retention in treatment.", "selection criteria": "We included randomised controlled trials with individuals using drugs, alcohol, or both. Interventions were MI or motivational enhancement therapy (MET), delivered individually and face to face. Eligible control interventions were no intervention, treatment as usual, assessment and feedback, or other active intervention."}, "labels": ["28132704", "27543208", "32898141", "28536655", "16012278", "17374038", "16945487", "17663610", "23421576", "21988576", "22743160", "17707594", "21766975", "15988430", "20141454", "20053238", "16187809", "22924334", "27070727", "26098125", "19930236", "22119179", "26362000", "17032098", "21059184", "16169159", "17032099", "17645430", "19803579", "31330464", "29750362", "28287800", "30640505", "12362966", "11239727", "11551733", "18037603", "17306724", "30138016", "24969735", "21928866", "12107041", "25040898", "15699056", "17891666", "33749294", "20493644", "32981123", "18054445", "24961378", "16996224", "18339108", "15301659", "15370020", "19299087", "19207345", "11070529", "25486391", "36166981", "35172248", "12901447", "11702799", "16392975", "15279529", "30487876", "16771893", "17869051", "16968350", "29247636", "20673621", "17949392", "9583332", "27936374", "34014691", "9926538", "35025543", "9756046", "8979210", "9811084", "8116822", "9581001", "12033698", "18192203", "20491723", "18080061", "11925053", "21440994", "18778385", "24773573", "24899076", "12924680", "30958012", "26985726", "19634958", "22905896", "28956934", "21198224", "26167945", "22191456", "20413077", "29706170", "17905800", "17014283", "16971296", "16539572", "18077833", "24364800", "16938063", "15200582", "17283347", "27886657", "25096690", "19538921", "18612575", "11414349", "23895088", "23054350", "25736623", "12084138", "18657938", "18714713", "20402990", "20201934", "28865169", "17523990", "11680565", "17347121", "34305196", "26727409", "19290699", "21733833", "19147800", "18547778", "16150765", "16150764", "18070238", "21145181", "19207347", "16822119", "19170454", "19170456", "16562414", "17550361", "19101099", "22710564", "28254158", "18083322", "17563146", "20025374", "17658696"]}
{"metadata": {"review_pmid": "38084761"}, "inputs": {"background": "Pompe disease is caused by a deficiency of the enzyme acid alpha-glucosidase (GAA). People with infantile-onset disease have either a complete or a near-complete enzyme deficiency; people with late-onset Pompe disease (LOPD) retain some residual enzyme activity. GAA deficiency is treated with an intravenous infusion of recombinant human acid alglucosidase alfa, an enzyme replacement therapy (ERT). Alglucosidase alfa and avalglucosidase alfa are approved treatments, but cipaglucosidase alfa with miglustat is not yet approved.", "objectives": "To assess the effects of enzyme replacement therapies in people with late-onset Pompe disease.", "selection criteria": "We included randomised controlled trials (RCTs) of ERT in people with LOPD of any age."}, "labels": ["34800399", "35305341", "30025991", "31839530", "34800400", "21543987", "20393176"]}
{"metadata": {"review_pmid": "38078559"}, "inputs": {"background": "Many children undergo various surgeries, which often lead to acute postoperative pain. This pain influences recovery and quality of life. Non-steroidal anti-inflammatory drugs (NSAIDs), specifically cyclo-oxygenase (COX) inhibitors such as diclofenac, can be used to treat pain and reduce inflammation. There is uncertainty regarding diclofenac's benefits and harms compared to placebo or other drugs for postoperative pain.", "objectives": "To assess the efficacy and safety of diclofenac (any dose) for acute postoperative pain management in children compared with placebo, other active comparators, or diclofenac administered by different routes (e.g. oral, rectal, etc.) or strategies (e.g. 'as needed' versus 'as scheduled').", "selection criteria": "We included randomised controlled trials (RCTs) in children under 18 years of age undergoing surgery that compared diclofenac (delivered in any dose and route) to placebo or any active pharmacological intervention. We included RCTs comparing different administration routes of diclofenac and different strategies."}, "labels": ["17593012", "1489038", "3377147", "16108749", "25260983", "20129679", "29782196", "8842656", "9742535", "19475212", "21959480", "2321721", "9189968", "10536549", "11119198", "28535959", "17319338", "17991260", "7906104", "10714842", "11013193", "10364873", "11939442", "8460760", "3421455", "11952445"]}